384 Plate ID,Plate Map,Well,Human Readable Name,Catalog No.,MoleculeID,Concentration,Unit,Well X,Well Y,Volume,Barcode,M.w.,CAS Number,Form,Targets,Information,Smiles,Max Solubility in DMSO,URL,Pathway,Notes,Library
SelleckChem001,SP0135-A,A01,DMSO_A01,,DMSO_A01,,,1,1,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A02,DMSO_A02,,DMSO_A02,,,2,1,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A03,Nintedanib (BIBF 1120),S1010,Nintedanib (BIBF 1120),10,m,3,1,25,179703356,539.62,656247-17-5,free base,VEGFR;PDGFR;FGFR,Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3; FGFR1/2/3 and PDGFR_/_ with IC50 of 34 nM/13 nM/13 nM; 69 nM/37 nM/108 nM and 59 nM/65 nM. Phase 3.,C1=C(C=C2C(=C1)/C(C(N2)=O)=C(\C3=CC=CC=C3)NC4=CC=C(C=C4)N(C)C(CN5CCN(CC5)C)=O)C(OC)=O,11,http://www.selleckchem.com/products/BIBF1120.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A04,Everolimus (RAD001),S1120,Everolimus (RAD001),10,m,4,1,25,192919554,958.22,159351-69-6,free base,mTOR,Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM.,C(O)CO[C@H]1[C@@H](C[C@@H](CC1)C[C@@H]([C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C([C@]4([C@@H](CC[C@H](O4)C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C([C@@H]([C@@H](O)/C(=C/[C@H](C(C2)=O)C)C)OC)=O)C)C)C)OC)C)O)=O)C)OC,104.36,http://www.selleckchem.com/products/Everolimus(RAD001).html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A05,Dasatinib,S1021,Dasatinib,10,m,5,1,25,194475652,488.01,302962-49-8,free base,Bcr-Abl;c-Kit;Src,Dasatinib is a novel; potent and multi-targeted inhibitor that targets Abl; Src and c-Kit; with IC50 of _1 nM; 0.8 nM and 79 nM; respectively.,N1=C(N=C(C=C1NC2=NC=C(S2)C(NC3=C(C=CC=C3C)Cl)=O)N4CCN(CC4)CCO)C,200.82,http://www.selleckchem.com/products/Dasatinib.html,Angiogenesis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A06,AT9283,S1134,AT9283,10,m,6,1,25,192886530,381.43,896466-04-9,free base,JAK;Aurora Kinase;Bcr-Abl,AT9283 is a potent JAK2/3 inhibitor with IC50 of 1.2 nM/1.1 nM; also potent to Aurora A/B; Abl(T315I). Phase 1/2.,N(C(=O)NC1C(=NNC=1)C2NC3C(N=2)=CC(=CC=3)CN4CCOCC4)C5CC5,199.25,http://www.selleckchem.com/products/AT9283.html,JAK/STAT,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A07,Motesanib Diphosphate (AMG-706),S1032,Motesanib Diphosphate (AMG-706),10,m,7,1,25,192902871,569.44,857876-30-3,diphosphate,VEGFR;PDGFR;c-Kit,Motesanib Diphosphate (AMG-706) is a potent ATP-competitive inhibitor of VEGFR1/2/3 with IC50 of 2 nM/3 nM/6 nM; respectively; similar activity against Kit; ~10-fold more selective for VEGFR than PDGFR and Ret. Phase 1/2.,C1(=CN=CC=C1CNC2=C(C=CC=N2)C(=O)NC3=CC=C4C(=C3)NCC4(C)C).P(O)(=O)(O)O.P(O)(=O)(O)O,175.61,http://www.selleckchem.com/products/Motesanib-Diphosphate.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A08,Ivacaftor (VX-770),S1144,Ivacaftor (VX-770),10,m,8,1,25,192928304,392.49,873054-44-5,free base,CFTR,Ivacaftor (VX-770) is a potentiator of CFTR targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM; respectively.,C1=C(C(=CC(=C1C(C)(C)C)NC(C2C(C3=C(NC=2)C=CC=C3)=O)=O)O)C(C)(C)C,198.73,http://www.selleckchem.com/products/VX-770.html,Transmembrane Transporters,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A09,STF-62247,S1041,STF-62247,10,m,9,1,25,179764897,267.35,315702-99-9,free base,Others,STF-62247 shows selectivtoxicity and growth inhibition of renal cells lacking VHL; 25-fold greater sensitivity observed for cells with VHL deficiency compared to wild-type (VHL+).,N1=CC=C(C=C1)C2=CSC(=N2)NC3=CC=CC(=C3)C,198.24,http://www.selleckchem.com/products/STF-62247.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A10,S3I-201,S1155,S3I-201,10,m,10,1,25,192949768,365.36,501919-59-1,free base,STAT,S3I-201 shows potent inhibition of STAT3 DNA-binding activity with IC50 of 86 _M; and low activity towards STAT1 and STAT5.,C1(=CC=C(C=C1)S(OCC(NC2=CC=C(C(=C2)O)C(O)=O)=O)(=O)=O)C,199.8,http://www.selleckchem.com/products/S31-201.html,JAK/STAT,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A11,Y-27632 2HCl,S1049,Y-27632 2HCl,10,m,11,1,25,194486667,320.26,129830-38-2,dihydrochloric,Autophagy;ROCK,Y-27632 2HCl is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM; exhibits >200-fold selectivity over other kinases; including PKC; cAMP-dependent protein kinase; MLCK and PAK.,[C@@H]1(CC[C@@H](CC1)[C@@H](C)N)C(=O)NC2(C=CN=CC=2).Cl.Cl,199.84,http://www.selleckchem.com/products/Y-27632.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A12,ABT-751 (E7010),S1165,ABT-751 (E7010),10,m,12,1,25,179764939,371.41,141430-65-1,free base,Microtubule Associated,ABT-751 (E7010) binds to the colchicine site on _-tubulin and inhibits polymerization of microtubules; not a substrate for the MDR transporter and is active against cell lines resistant to vincristine; doxorubicin; and cisplatin. Phase 1/2.,C1=C(C=CC(=C1)S(=O)(=O)NC2=C(N=CC=C2)NC3=CC=C(C=C3)O)OC,199.24,http://www.selleckchem.com/products/ABT-751.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A13,Masitinib (AB1010),S1064,Masitinib (AB1010),10,m,13,1,25,192880604,498.64,790299-79-5,free base,PDGFR;c-Kit,Masitinib is a novel inhibitor for Kit and PDGFR_/_ with IC50 of 200 nM and 540 nM/800 nM; weak inhibition to ABL and c-Fms. Phase 2/3.,C1(=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CC=CN=C5)C,200.55,http://www.selleckchem.com/products/Masitinib-(AB1010).html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A14,WZ4002,S1173,WZ4002,10,m,14,1,25,192873716,494.18,1213269-23-8,free base,EGFR,WZ4002 is a novel; mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with IC50 of 2 nM/8 nM; does not inhibit ERBB2 phosphorylation (T798I).,C1(=CC(=C(C=C1)NC2=NC=C(C(=N2)OC3=CC(=CC=C3)NC(C=C)=O)Cl)OC)N4CCN(CC4)C,26.31,http://www.selleckchem.com/products/WZ4002.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A15,ZSTK474,S1072,ZSTK474,10,m,15,1,25,194486611,417.41,475110-96-4,free base,PI3K,ZSTK474 inhibits class I PI3Kisoforms with IC50 of 37 nM; mostly PI3K_. ,N1=C(N=C(N=C1N2CCOCC2)N3C4=C(N=C3C(F)F)C=CC=C4)N5CCOCC5,50.31,http://www.selleckchem.com/products/ZSTK474.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A16,ENMD-2076,S1181,ENMD-2076,10,m,16,1,25,192878412,375.47,934353-76-1,tartaric acid,Aurora Kinase;FLT3;VEGFR,ENMD-2076 has selective activity against Aurora A and Flt3 with IC50 of 14 nM and 1.86 nM; 25-fold selective for Aurora A than over Aurora B and less potent to VEGFR2/KDR and VEGFR3; FGFR1 and FGFR2 and PDGFR_. Phase 2.,C1(N=C(C=C(N=1)N2CCN(CC2)C)NC3=NNC(=C3)C)/C=C/C4C=CC=CC=4,279.65,http://www.selleckchem.com/products/ENMD-2076.html,Angiogenesis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A17,Belinostat (PXD101),S1085,Belinostat (PXD101),10,m,17,1,25,179703483,318.35,414864-00-9,free base,HDAC,Belinostat (PXD101) is a novel HDAC inhibitor with IC50 of 27 nM; with activity demonstrated in cisplatin-resistant tumors. Phase 1/2.,C1(=CC=CC(=C1)/C=C/C(NO)=O)S(NC2=CC=CC=C2)(=O)=O,201.04,http://www.selleckchem.com/products/Belinostat.html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A18,Raltitrexed,S1192,Raltitrexed,10,m,18,1,25,192949042,458.49,112887-68-0,free base,DNA/RNA Synthesis,Raltitrexed is a thymidylate synthase inhibitor with an IC50 of 9 nM for the inhibition of L1210 cell growth.,C([C@H](CCC(=O)O)NC(=O)C1=CC=C(S1)N(CC2=CC3C(NC(=NC(C=C2)=3)C)=O)C)(=O)O,200.66,http://www.selleckchem.com/products/Raltitrexed.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A19,PF-04217903,S1094,PF-04217903,10,m,19,1,25,192887524,372.38,956905-27-4,free base,c-Met,PF-04217903 is a selective ATP-competitive c-Met inhibitor with IC50 of 4.8 nM; susceptible to oncogenic mutations (no activity to Y1230C mutant). Phase 1.,C12=CC=CN=C1C=CC(=C2)CN3C4=C(N=N3)N=CC(=N4)C5=CN(N=C5)CCO,13.43,http://www.selleckchem.com/products/PF-04217903.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A20,Decitabine,S1200,Decitabine,10,m,20,1,25,192931507,228.21,2353-33-5,free base,DNA Methyltransferase,Decitabine is a potent inhibitor of DNA methylation with IC50 of 438 nM and 4.38 nM in HL-60 and KG1a cells; respectively.,[C@H]1(O[C@@H]([C@H](C1)O)CO)N2C=NC(=NC2=O)N,201.57,http://www.selleckchem.com/products/Decitabine.html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A21,ZM 447439,S1103,ZM 447439,10,m,21,1,25,192885483,513.59,331771-20-1,free base,Aurora Kinase,ZM 447439 is a selective and ATP-competitive inhibitor for Aurora A and Aurora B with IC50 of 110 nM and 130 nM; respectively. It is more than 8-fold selective for Aurora A/B than MEK1; Src; Lck and has little effect againstCDK1/2/4; Plk1; Chk1; etc.,O1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CN=C3NC4=CC=C(C=C4)NC(=O)C5=CC=CC=C5)OC,200.55,http://www.selleckchem.com/products/ZM-447439.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,A22,Fluorouracil (5-Fluoracil; 5-FU),S1209,Fluorouracil (5-Fluoracil; 5-FU),10,m,22,1,25,192879364,130.08,51-21-8,free base,DNA/RNA Synthesis,Fluorouracil (5-Fluoracil; 5-FU) is an DNA/RNA synthesis inhibitor; which interrupts nucleotide synthetic by inhibiting thymidylate synthase (TS).,C1(NC(C(=CN1)F)=O)=O,199.88,http://www.selleckchem.com/products/Adrucil(Fluorouracil).html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B01,DMSO_B01,,DMSO_B01,,,1,2,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B02,DMSO_B02,,DMSO_B02,,,2,2,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B03,Idarubicin HCl,S1228,Idarubicin HCl,10,m,3,2,25,192878950,533.95,57852-57-0,hydrochloride,Topoisomerase,Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL.,C1(=CC=C2C(=C1)C(C3=C(C2=O)C(=C4C(=C3O)[C@@H](C[C@@](C4)(C(C)=O)O)O[C@@H]5O[C@H]([C@H]([C@H](C5)N)O)C)O)=O).Cl,187.28,http://www.selleckchem.com/products/Idarubicin.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B04,Ruxolitinib (INCB018424),S1378,Ruxolitinib (INCB018424),10,m,4,2,25,192866444,306.37,941678-49-5,free base,JAK,INCB018424 is the first potent; selective; JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM; >130-fold selectivity for JAK1/2 versus JAK3. Phase 3.,N1=CN=C2C(=C1C3=CN(N=C3)[C@@H](CC#N)C4CCCC4)C=CN2,199.11,http://www.selleckchem.com/products/INCB18424.html,JAK/STAT,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B05,Agomelatine,S1243,Agomelatine,10,m,5,2,25,192931287,243.3,138112-76-2,free base,5-HT Receptor,Agomelatine is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor.,C(C)(=O)NCCC1C=CC=C2C=CC(=CC=12)OC,201.4,http://www.selleckchem.com/products/Agomelatine.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B06,Omeprazole ,S1389,Omeprazole ,10,m,6,2,25,192961264,345.42,73590-58-6,free base,Autophagy;Proton Pump,Omeprazole(Prilosec) is a proton pump inhibitor used in the treatment of dyspepsia.,C1=C(C=C2C(=C1)NC(=N2)S(=O)CC3=C(C(=C(C=N3)C)OC)C)OC,199.76,http://www.selleckchem.com/products/Omeprazole.html,Transmembrane Transporters,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B07,Nepafenac,S1255,Nepafenac,10,m,7,2,25,192864283,254.28,78281-72-8,free base,Others,Nepafenac is a non-steroidal anti-inflammatory agent.,C(CC1C(=C(C=CC=1)C(C2C=CC=CC=2)=O)N)(=O)N,200.57,http://www.selleckchem.com/products/Nepafenac.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B08,Stavudine (d4T),S1398,Stavudine (d4T),10,m,8,2,25,192917480,224.21,3056-17-5,free base,Reverse Transcriptase,Stavudine is a nucleoside analog reverse transcriptase inhibitor (NARTI) active against HIV. ,O1C(C=CC1CO)N2C(NC(C(=C2)C)=O)=O,200.7,http://www.selleckchem.com/products/Stavudine.html,Microbiology,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B09,PD173074,S1264,PD173074,10,m,9,2,25,192944853,523.67,219580-11-7,free base,VEGFR;FGFR,PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM; ~1000-fold selective for FGFR1 than PDGFR and c-Src.,N1=C(N=C2C(=C1)C=C(C(=N2)NC(NC(C)(C)C)=O)C3=CC(=CC(=C3)OC)OC)NCCCCN(CC)CC,190.96,http://www.selleckchem.com/products/PD-173074.html,Angiogenesis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B10,Clopidogrel,S1415,Clopidogrel,10,m,10,2,25,192879174,419.9,120202-66-6,sulfate,P2 Receptor,Clopidogrel (Plavix) is an oral; thienopyridine class antiplatelet agent.,C1(=CC=CC(=C1Cl)[C@H](N2CCC3=C(C2)C=CS3)C(=O)OC).OS(O)(=O)=O,200.05,http://www.selleckchem.com/products/Clopidogrel-bisulfate.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B11,Amisulpride,S1280,Amisulpride,10,m,11,2,25,192880261,369.48,71675-85-9,free base,Dopamine Receptor,Amisulpride is an atypical antipsychotic used to treat psychosis in schizophrenia and episodes of mania in bipolar disorder.,C1C(N(CC1)CC)CNC(C2=CC(=C(C=C2OC)N)S(CC)(=O)=O)=O,200.28,http://www.selleckchem.com/products/Amisulpride.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B12,Tizanidine HCl,S1437,Tizanidine HCl,10,m,12,2,25,192879035,290.17,64461-82-1,hydrochloride,Adrenergic Receptor,Tizanidine HCl is an _2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons.,C1(C=CC2C(C=1NC3NCCN=3)=NSN=2)Cl.Cl,34.46,http://www.selleckchem.com/products/Tizanidine-hydrochloride.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B13,Camptothecin,S1288,Camptothecin,10,m,13,2,25,192885654,348.35,7689-3-4,free base,Topoisomerase,Camptothecin is a specific inhibitor of DNA topoisomerase I (Topo I) with IC50 of 0.68 _M. Phase 2.,O1C([C@@](C2=C(C1)C(N3C(=C2)C4=C(C3)C=C5C(=N4)C=CC=C5)=O)(CC)O)=O,5.74,http://www.selleckchem.com/products/Camptothecine.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B14,Nanchangmycin,S1450,Nanchangmycin,10,m,14,2,25,192917475,889.1,65101-87-3,free base,Others,Nanchangmycin (dianemycin) is a polyether antibiotic with similar structure to dianemycin and is very active against a broad spectrum of harmful nematodes and insects but not for for mammals and plants.,[O-]C([C@H](C[C@@H](C)C(/C(=C/[C@@H]([C@]1(O[C@]2(C[C@@H]([C@@H]1C)O)CC[C@](O2)([C@@]3(O[C@]4([C@@H]([C@H](C3)OC5O[C@@H]([C@H](CC5)OC)C)C)[C@H](C[C@@](O4)([C@]6(O[C@]([C@@H](C[C@H]6C)C)(CO)O)[H])[H])C)[H])C)[H])C)C)=O)C)=O.[Na+],112.47,http://www.selleckchem.com/products/Nanchangmycin.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B15,Ifosfamide,S1302,Ifosfamide,10,m,15,2,25,192897078,261.09,3778-73-2,free base,DNA/RNA Synthesis,Ifosfamide is a nitrogen mustard alkylating agent used in the treatment of cancer.,C1COP(N(C1)CCCl)(NCCCl)=O,199.17,http://www.selleckchem.com/products/Ifosfamide.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B16,VX-745,S1458,VX-745,10,m,16,2,25,192885380,436.26,209410-46-8,free base,p38 MAPK,VX-745 is a potent and selective inhibitor of p38_ with IC50 of 10 nM; 22-fold greater selectivity versus p38_ and no inhibition to p38_.,C1=C(C=CC(=C1F)SC2C=CC3N(N=2)C=NC(C=3C4=C(C=CC=C4Cl)Cl)=O)F,34.38,http://www.selleckchem.com/products/VX-745.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B17,Edaravone,S1326,Edaravone,10,m,17,2,25,192897247,174.2,89-25-8,free base,Others,Edaravone; a strong novel free radical scavenger; is used for treatment of patients with acute brain infarction.,C1(CC(N(N=1)C2=CC=CC=C2)=O)C,200.92,http://www.selleckchem.com/products/Edaravone.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B18,Calcifediol,S1469,Calcifediol,10,m,18,2,25,192881430,400.64,19356-17-3,free base,Others,Calcifediol is a major circulating metabolite of vitamin D3 and acts as a competitive inhibitor with an apparent Ki of 3.9 _M. It also suppresses PTH secretion and mRNA (ED50=2 nM),C1[C@H](CCC(C/1=C/C=C2/[C@]3([C@](CCC2)([C@]([C@@H](CCCC(C)(C)O)C)(CC3)[H])C)[H])=C)O,199.68,http://www.selleckchem.com/products/Calcifediol.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B19,Fluvoxamine maleate,S1336,Fluvoxamine maleate,10,m,19,2,25,192886991,434.41,61718-82-9,maleate,5-HT Receptor,Fluvoxamine maleate is a selective serotonin (5-HT) reuptake inhibitor (SSRI).,C1(=CC=C(C=C1)/C(CCCCOC)=N/OCCN)C(F)(F)F.C(/C(=O)O)=C\C(=O)O,200.27,http://www.selleckchem.com/products/Fluvoxamine-maleate.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B20,Zosuquidar (LY335979) 3HCl,S1481,Zosuquidar (LY335979) 3HCl,10,m,20,2,25,179680079,636.99,167465-36-3,hydrochloride,P-gp,Zosuquidar (LY335979) is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM. Phase 3.,C12(=C(C=CC=C1OC[C@@H](CN3CCN(CC3)[C@@H]4C5=C([C@@H]6[C@H](C7=C4C=CC=C7)C(F)(F)6)C=CC=C5)O)N=CC=C2).Cl.Cl.Cl,156.99,http://www.selleckchem.com/products/LY335979.html,Transmembrane Transporters,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B21,Levetiracetam,S1356,Levetiracetam,10,m,21,2,25,192897010,170.21,102767-28-2,free base,Others,Levetiracetam is an antiepileptic compound.,C1(N(CCC1)[C@H](C(N)=O)CC)=O,199.75,http://www.selleckchem.com/products/Levetiracetam.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,B22,PIK-93,S1489,PIK-93,10,m,22,2,25,192962591,389.88,593960-11-3,free base,PI3K,PIK-93 is the first potent; synthetic PI4K (PI4KIII_) inhibitor with IC50 of 19 nM; shown to inhibit PI3K_ with IC50 of 39 nM.,C1(=C(C=C(C=C1)C2SC(=NC=2C)NC(C)=O)S(=O)(=O)NCCO)Cl,200.06,http://www.selleckchem.com/products/PIK-93.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C01,DMSO_C01,,DMSO_C01,,,1,3,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C02,DMSO_C02,,DMSO_C02,,,2,3,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C03,Afatinib (BIBW2992),S1011,Afatinib (BIBW2992),10,m,3,3,25,192903248,485.94,439081-18-2,free base,EGFR;HER2,Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt); EGFR(L858R); EGFR(L858R/T790M) and HER2 with IC50 of 0.5 nM; 0.4 nM; 10 nM and 14 nM; respectively; 100-fold more active against Gefitinib-resistant L858R-T790M EGFR mutant. Phase 3.,C1(=C(C=C(C=C1)NC2=NC=NC3=C2C=C(C(=C3)O[C@H]4CCOC4)NC(/C=C/CN(C)C)=O)Cl)F,199.61,http://www.selleckchem.com/products/BIBW2992.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C04,TW-37,S1121,TW-37,10,m,4,3,25,192950585,573.7,877877-35-5,free base,Bcl-2,TW-37 is a novel nonpeptide inhibitor to recombinant Bcl-2; Bcl-xL and Mcl-1 with Ki of 0.29 _M; 1.11 _M and 0.26 _M; respectively.,C1=CC=CC(=C1C(C)(C)C)S(C2=CC=C(C=C2)NC(C3=C(C(=C(C(=C3)CC4=CC=CC=C4C(C)C)O)O)O)=O)(=O)=O,200.45,http://www.selleckchem.com/products/TW-37.html,Apoptosis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C05,Ridaforolimus (Deforolimus; MK-8669),S1022,Ridaforolimus (Deforolimus; MK-8669),10,m,5,3,25,192903205,990.21,572924-54-0,free base,mTOR,Ridaforolimus (Deforolimus) is a selective mTOR inhibitor with IC50 of 0.2 nM; while not classified as a prodrug; mTOR inhibition and FKBP12 binding is similar to rapamycin.,[C@H]1(C[C@@H](CC[C@@H]1OP(C)(=O)C)C[C@H]([C@@H]2CC([C@@H](/C=C(/[C@H]([C@@H](OC)C([C@@H](C[C@@H](/C=C/C=C/C=C(/[C@H](C[C@]3(CC[C@H]([C@](C(C(N4[C@](C(O2)=O)(CCCC4)[H])=O)=O)(O3)O)C)[H])OC)C)C)C)=O)O)C)C)=O)C)OC,199.96,http://www.selleckchem.com/products/Deforolimus.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C06,Malotilate,S1137,Malotilate,10,m,6,3,25,192880842,288.38,59937-28-9,free base,Others,Malotilate is a liver protein metabolism improved compound.,C(C(C(=O)OC(C)C)=C1SC=CS1)(=O)OC(C)C,201.12,http://www.selleckchem.com/products/Malotilate.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C07,Nilotinib (AMN-107),S1033,Nilotinib (AMN-107),10,m,7,3,25,192919540,529.52,641571-10-0,free base,Bcr-Abl,Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM.,C1(=CC=C(C(=C1)NC2=NC=CC(=N2)C3=CN=CC=C3)C)C(=O)NC4=CC(=CC(=C4)N5C=C(N=C5)C)C(F)(F)F,50.99,http://www.selleckchem.com/products/Nilotinib.html,Angiogenesis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C08,SNS-032 (BMS-387032),S1145,SNS-032 (BMS-387032),10,m,8,3,25,194487284,380.53,345627-80-7,free base,CDK,SNS-032 has firstly been described as a selective inhibitor of CDK2 with IC50 of 48 nM and is 10- and 20-fold selective over CDK1/CDK4. It is also found to be sensitive to CDK7/9 with IC50 of 62 nM/4 nM; with little effect on CDK6. Phase 1.,C1(=CN=C(O1)CSC2=CN=C(S2)NC(=O)C3CCNCC3)C(C)(C)C,199.72,http://www.selleckchem.com/products/SNS-032.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C09,Sunitinib Malate,S1042,Sunitinib Malate,10,m,9,3,25,192919538,532.56,341031-54-7,malate,VEGFR;PDGFR;c-Kit,Sunitinib Malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFR_ with IC50 of 80 nM and 2 nM; and also inhibits c-Kit.,C1(=CC=C2C(=C1)/C(C(N2)=O)=C/C3NC(=C(C=3C)C(NCCN(CC)CC)=O)C)F.C(C[C@@H](C(O)=O)O)(O)=O,28.17,http://www.selleckchem.com/products/Sunitinib-Malate-(Sutent).html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C10,Capecitabine ,S1156,Capecitabine ,10,m,10,3,25,192928221,359.35,154361-50-9,free base,DNA/RNA Synthesis,Capecitabine is a tumor-selective fluoropyrimidine carbamate which achieves higher intratumoral 5-FU level with lower toxicity than 5-FU.,N1=C(C(=CN(C1=O)[C@@H]2O[C@@H]([C@H]([C@@H]2O)O)C)F)NC(OCCCCC)=O,200.36,http://www.selleckchem.com/products/Capecitabine(Xeloda).html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C11,Elesclomol (STA-4783),S1052,Elesclomol (STA-4783),10,m,11,3,25,192949418,400.5,488832-69-5,free base,HSP (e.g. HSP90),Elesclomol (STA-4783) is a novel potent oxidative stress inducer that elicits pro-apoptosis events among tumor cells.,C1=CC=C(C=C1)C(N(NC(CC(NN(C)C(=S)C2=CC=CC=C2)=O)=O)C)=S,199.75,http://www.selleckchem.com/products/Elesclomol.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C12,Cisplatin,S1166,Cisplatin,10,m,12,3,25,192928301,300.05,15663-27-1,free base,DNA/RNA Synthesis,Cisplatin is an inorganic platinum complex; which is able to inhibit DNA synthesis by conforming DNA adducts. ,[Pt](N)(Cl)(Cl)N,0,http://www.selleckchem.com/products/Cisplatin.html,DNA Damage,DMF recommended over DMSO. 25 mM solubility in DMF,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C13,GDC-0941,S1065,GDC-0941,10,m,13,3,25,192885916,513.64,957054-30-7,free base,PI3K,GDC-0941 is a potent inhibitor of PI3K_/_ with IC50 of 3 nM; with modest selectivity against p110_ (11-fold) and p110_ (25-fold).,C1(=CC=CC2=C1C=NN2)C3=NC(=C4C(=N3)C=C(S4)CN5CCN(CC5)S(=O)(=O)C)N6CCOCC6,194.69,http://www.selleckchem.com/products/GDC-0941.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C14,MK-2866 (GTx-024),S1174,MK-2866 (GTx-024),10,m,14,3,25,192873765,389.33,841205-47-8,free base,Androgen Receptor,MK-2866 (GTx-024) is a selective androgen receptor modulator (SARM) with Ki of 3.8 nM; and is tissue-selective for anabolic organs. Phase 3.,C([C@@](COC1C=CC(=CC=1)C#N)(C)O)(=O)NC2C=C(C(=CC=2)C#N)C(F)(F)F,200.34,http://www.selleckchem.com/products/Ostarine.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C15,SB216763,S1075,SB216763,10,m,15,3,25,194486643,371.22,280744-09-4,free base,GSK-3,SB216763 is a potent and selective GSK-3 inhibitor with IC50 of 34.3 nM for GSK-3_ and equally effective at inhibiting human GSK-3_.,C1=CC=CC2=C1N(C=C2C3=C(C(NC3=O)=O)C4=CC=C(C=C4Cl)Cl)C,61.96,http://www.selleckchem.com/products/SB-216763.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C16,Danoprevir (ITMN-191),S1183,Danoprevir (ITMN-191),10,m,16,3,25,179735870,731.83,850876-88-9,free base,HCV Protease,Danoprevir(ITMN-191) is a peptidomimetic inhibitor of the NS3/4A protease of hepatitis C virus (HCV) with IC50 of 0.2-3.5 nM; inhibition effect for HCV genotypes 1A/1B/4/5/6 is ~10-fold higher than 2B/3A. Phase 2.,[C@@H]1(CN2[C@@H](C1)C(N[C@@]3(C(NS(=O)(=O)C4CC4)=O)[C@@H](C3)/C=C\CCCCC[C@@H](C2=O)NC(OC(C)(C)C)=O)=O)OC(N5CC6=C(C5)C(=CC=C6)F)=O,196.77,http://www.selleckchem.com/products/Danoprevir.html,Proteases,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C17,Iniparib (BSI-201),S1087,Iniparib (BSI-201),10,m,17,3,25,192897757,292.03,160003-66-7,free base,PARP,BSI-201 (Iniparib; SAR240550) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3.,C1=CC(=C(C=C1C(N)=O)[N+](=O)[O-])I,198.61,http://www.selleckchem.com/products/BSI-201.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C18,Thalidomide,S1193,Thalidomide,10,m,18,3,25,179700993,258.23,50-35-1,free base,TNF-alpha;E3 Ligase ,Thalidomide was introduced as a sedative drug; immunomodulatory agent and also is investigated for treating symptoms of many cancers. Thalidomide inhibits an E3 ubiquitin ligase; which is a CRBN-DDB1-Cul4A complex.Phase 3.,C1(N(C(C2C=CC=CC1=2)=O)C3C(NC(CC3)=O)=O)=O,201.37,http://www.selleckchem.com/products/Thalidomide.html,Apoptosis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C19,LAQ824 (Dacinostat),S1095,LAQ824 (Dacinostat),10,m,19,3,25,192898122,379.459,404951-53-7,free base,HDAC,LAQ824 (Dacinostat) is a novel HDAC inhibitor with IC50 of 32 nM and is known to activate the p21 promoter.,C1(=CC=C(C=C1)CN(CCO)CCC2=CNC3=C2C=CC=C3)/C=C/C(NO)=O,200.29,http://www.selleckchem.com/products/LAQ824(NVP-LAQ824).html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C20,Dimesna,S1201,Dimesna,10,m,20,3,25,179711150,326.34,16208-51-8,free base,Others,Dimesna is an uroprotective agent used to decrease urotoxicity.,S(CCSSCCS([O-])(=O)=O)([O-])(=O)=O.[Na+].[Na+],199.18,http://www.selleckchem.com/products/Dimesna.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C21,GDC-0879,S1104,GDC-0879,10,m,21,3,25,179704249,334.37,905281-76-7,free base,Raf,GDC-0879 is a novel; potent; and selective B-Raf inhibitor with IC50 of 0.13 nM with activity against c-Raf as well; no inhibition known to other protein kinases.,C(CN1N=C(C(=C1)C2=CC=C3C(=C2)CCC/3=N/O)C4C=CN=CC=4)O,200.38,http://www.selleckchem.com/products/GDC-0879.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,C22,Methotrexate,S1210,Methotrexate,10,m,22,3,25,192959704,454.44,59-05-2,free base,DHFR,Methotrexate is an antimetabolite and antifolate drug; which acts by inhibiting the metabolism of folic acid.,N1=C(N=C2C(=C1N)N=C(C=N2)CN(C3=CC=C(C=C3)C(N[C@@H](CCC(=O)O)C(=O)O)=O)C)N,200.25,http://www.selleckchem.com/products/Abitrexate.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D01,DMSO_D01,,DMSO_D01,,,1,4,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D02,DMSO_D02,,DMSO_D02,,,2,4,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D03,Fludarabine Phosphate,S1229,Fludarabine Phosphate,10,m,3,4,25,192958962,365.21,75607-67-9,phosphate,DNA/RNA Synthesis,Fludarabine Phosphate is an analogue of adenosine and deoxyadenosine; which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis.,N1C(=NC2=C(C=1N)N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)F,199.88,http://www.selleckchem.com/products/Fludara.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D04,Isotretinoin,S1379,Isotretinoin,10,m,4,4,25,192958410,300.44,4759-48-2,free base,Hydroxylase,It was developed to be used as a chemotherapy medication for the treatment of brain cancer; pancreatic cancer and more.,C(/C=C(\C=C\C=C(/C=C/C1=C(CCCC1(C)C)C)C)C)(=O)O,199.71,http://www.selleckchem.com/products/Isotretinoin.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D05,Amuvatinib (MP-470),S1244,Amuvatinib (MP-470),10,m,5,4,25,192939905,447.51,850879-09-3,free base,FLT3;c-RET;PDGFR;c-Kit,Amuvatinib (MP-470) is a potent and multi-targeted inhibitor of c-Kit; PDGFR_ and Flt3 with IC50 of 10 nM; 40 nM and 81 nM; respectively. Phase 2.,C1=CC=C2C(=C1)C3=C(O2)C(=NC=N3)N4CCN(CC4)C(=S)NCC5=CC=C6C(=C5)OCO6,71.51,http://www.selleckchem.com/products/MP-470.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D06,Ondansetron HCl,S1390,Ondansetron HCl,10,m,6,4,25,192878299,329.82,99614-01-4,hydrochloride,5-HT Receptor,Ondansetron HCl is a serotonin 5-HT3 receptor antagonist. ,C1(=CC=C2C(=C1)C3=C(N2C)CCC(C3=O)CN4C(=NC=C4)C).Cl,200.11,http://www.selleckchem.com/products/Ondansetron-hydrochloride.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D07,Rufinamide,S1256,Rufinamide,10,m,7,4,25,192878311,238.19,106308-44-5,free base,Sodium Channel,Rufinamide; a triazole derivative; is an anticonvulsant medication.,C1=CC=C(C(=C1F)CN2N=NC(=C2)C(=O)N)F,201.52,http://www.selleckchem.com/products/Rufinamide.html,Transmembrane Transporters,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D08,Tenofovir Disoproxil Fumarate,S1400,Tenofovir Disoproxil Fumarate,10,m,8,4,25,192877856,635.51,202138-50-9,fumarate,Reverse Transcriptase,Tenofovir disoproxil fumarate belongs to nucleotide analogue reverse transcriptase inhibitors (nRTIs). ,N1(C=NC2=C(C=1N)N=CN2C[C@H](OCP(OCOC(OC(C)C)=O)(OCOC(=O)OC(C)C)=O)C).C(=C/C(=O)O)/C(=O)O,201.41,http://www.selleckchem.com/products/Tenofovir-Disoproxil-Fumarate.html,Microbiology,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D09,WYE-354,S1266,WYE-354,10,m,9,4,25,194487243,495.53,1062169-56-5,free base,mTOR,WYE-354 is a potent; specific and ATP-competitive inhibitor of mTOR with IC50 of 5 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) not P-AKT(T308); selective for mTOR than PI3K_ (>100-fold) and PI3K_ (>500-fold). ,C1=C(C=CC(=C1)C2=NC3=C(C(=N2)N4CCOCC4)C=NN3C5CCN(CC5)C(=O)OC)NC(OC)=O,199.79,http://www.selleckchem.com/products/WYE-354.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D10,Droxinostat,S1422,Droxinostat,10,m,10,4,25,192959059,243.69,99873-43-5,free base,HDAC,Droxinostat (CMH; 5809354) is a selective inhibitor of HDAC; mostly for HDACs 6 and 8 with IC50 of 2.47_M and 1.46 _M; greater than 8-fold selective against HDAC3 and no inhibition to HDAC1; 2; 4; 5; 7; 9; and 10.,C1=C(C=C(C(=C1)OCCCC(NO)=O)C)Cl,201.08,http://www.selleckchem.com/products/Droxinostat.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D11,Aniracetam,S1281,Aniracetam,10,m,11,4,25,179701044,219.24,72432-10-1,free base,AMPA Receptor-kainate Receptor-NMDA Receptor,Aniracetam is a nootropics and neuroprotective drug.,C1(=CC=C(C=C1)C(N2C(CCC2)=O)=O)OC,200.69,http://www.selleckchem.com/products/Aniracetam.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D12,Topiramate,S1438,Topiramate,10,m,12,4,25,194475209,339.36,97240-79-4,free base,Carbonic Anhydrase,Topiramate is an anticonvulsant compound.,[C@H]12[C@H]([C@H]3[C@](OC1)(COS(N)(=O)=O)OC(O3)(C)C)OC(O2)(C)C,200.38,http://www.selleckchem.com/products/Topiramate.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D13,Carmofur,S1289,Carmofur,10,m,13,4,25,192958533,257.26,61422-45-5,free base,DNA/RNA Synthesis,Carmofur is a pyrimidine analogue used as an antineoplastic agent.,C1(C(NC(N(C=1)C(NCCCCCC)=O)=O)=O)F,202.13,http://www.selleckchem.com/products/Carmofur.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D14,Aurora A Inhibitor I,S1451,Aurora A Inhibitor I,10,m,14,4,25,192959600,588.07,1158838-45-9,free base,Aurora Kinase,Aurora A Inhibitor I is a novel; potent; and selective inhibitor of Aurora A with IC50 of 3.4 nM. It is 1000-fold more selective for Aurora A than Aurora B.,N1=CC(=C(N=C1NC2=CC=C(C=C2)CC(N3CCN(CC3)CC)=O)NC4=CC=C(C=C4)C(NC5=CC=CC=C5Cl)=O)F,42.51,http://www.selleckchem.com/products/Aurora-A-Inhibitor-I.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D15,Megestrol Acetate,S1304,Megestrol Acetate,10,m,15,4,25,192880720,384.51,595-33-5,acetate,Estrogen/progestogen Receptor;Androgen Receptor,Megestrol Acetate is a synthetic progesteronal agent with an IC50 of 260 _M for the inhibition of HegG2.,C1C(C=C2[C@](C1)([C@]3([C@@](C=C2C)([C@]4([C@](CC3)([C@@](CC4)(C(C)=O)OC(=O)C)C)[H])[H])[H])C)=O,85.82,http://www.selleckchem.com/products/Megestrol-Acetate.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D16,Thiazovivin,S1459,Thiazovivin,10,m,16,4,25,192885679,311.36,1226056-71-8,free base,ROCK,Thiazovivin (Tzv) is a novel ROCK inhibitor with IC50 of 0.5 _M; promotes hESC survival after single-cell dissociation.,C1(SC=C(N=1)C(NCC2=CC=CC=C2)=O)NC3=CC=NC=N3,48.18,http://www.selleckchem.com/products/Thiazovivin.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D17,Etodolac ,S1328,Etodolac ,10,m,17,4,25,192879965,287.35,41340-25-4,free base,COX,Etodolac (Lodine) is a COX inhibitor with an IC50 of 53.5 nM.,C1=CC2=C(C(=C1)CC)NC3=C2CCO[C@]3(CC(=O)O)CC,201.84,http://www.selleckchem.com/products/Etodolac.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D18,TSU-68 (SU6668; Orantinib),S1470,TSU-68 (SU6668; Orantinib),10,m,18,4,25,192945281,310.35,252916-29-3,free base,VEGFR;PDGFR;FGFR,SU6668 has greatest potency against PDGFR autophosphorylation with Ki of 8 nM; but also strongly inhibits Flk-1 and FGFR1 trans-phosphorylation; little activity against IGF-1R; Met; Src; Lck; Zap70; Abl and CDK2; does not inhibit EGFR. Phase 3.,C1=CC=C2C(=C1)/C(C(N2)=O)=C/C3NC(=C(C=3C)CCC(O)=O)C,199.77,http://www.selleckchem.com/products/TSU-68(SU6668).html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D19,Genistein,S1342,Genistein,10,m,19,4,25,192879673,270.24,446-72-0,free base,Topoisomerase;EGFR,Genistein; a phytoestrogen found in soy products; is a highly specific inhibitor of protein tyrosine kinase (PTK)  which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12_M or by insulin with IC50 of 19 _M. ,C1(=CC2=C(C(=C1)O)C(C(=CO2)C3=CC=C(C=C3)O)=O)O,199.82,http://www.selleckchem.com/products/Genistein.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D20,Daclatasvir (BMS-790052),S1482,Daclatasvir (BMS-790052),10,m,20,4,25,192949020,738.88,1009119-64-5,free base,HCV Protease,BMS-790052 is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM; for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Phase 3.,C1=CC(=CC=C1C2=CN=C(N2)[C@H]3N(CCC3)C([C@H](C(C)C)NC(OC)=O)=O)C4=CC=C(C=C4)C5=CN=C(N5)[C@H]6N(CCC6)C([C@H](C(C)C)NC(OC)=O)=O,200.3,http://www.selleckchem.com/products/BMS-790052.html,Proteases,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D21,Lidocaine,S1357,Lidocaine,10,m,21,4,25,192885717,234.34,137-58-6,free base,Histamine Receptor,Lidocaine is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 _M.,C1=CC=C(C(=C1C)NC(CN(CC)CC)=O)C,200.56,http://www.selleckchem.com/products/Lidocaine.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,D22,Ponatinib (AP24534),S1490,Ponatinib (AP24534),10,m,22,4,25,192873247,532.56,943319-70-8,free base,PDGFR;FGFR;VEGFR;Bcr-Abl,Ponatinib (AP24534) is a novel; potent multi-target inhibitor of Abl; PDGFR_; VEGFR2; FGFR1 and Src with IC50 of 0.37 nM; 1.1 nM; 1.5 nM; 2.2 nM and 5.4 nM; respectively.,C1C=NN2C(C=1)=NC=C2C#CC3=C(C=CC(=C3)C(=O)NC4=CC(=C(C=C4)CN5CCN(CC5)C)C(F)(F)F)C,187.77,http://www.selleckchem.com/products/AP24534.html,Angiogenesis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E01,DMSO_E01,,DMSO_E01,,,1,5,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E02,DMSO_E02,,DMSO_E02,,,2,5,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E03,BMS-536924,S1012,BMS-536924,10,m,3,5,25,194482360,479.96,468740-43-4,Free Base,IGF-1R,BMS-536924 is an ATP-competitive IGF-1R/IR inhibitor with IC50 of 100 nM/73 nM; modest activity for Mek; Fak; and Lck with very little activity for Akt1; MAPK1/2. ,C1(=CC(=C2C(=C1)NC(=N2)C3=C(C=CNC3=O)NC[C@H](C4=CC=CC(=C4)Cl)O)C)N5CCOCC5,200.02,www.selleckchem.com/products/BMS-536924.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E04,Mocetinostat (MGCD0103),S1122,Mocetinostat (MGCD0103),10,m,4,5,25,179655853,396.44,726169-73-9,free base,HDAC,Mocetinostat (MGCD0103) is a potent HDAC inhibitor with most potency for HDAC1 with IC50 of 0.15 _M; 2- to 10- fold selectivity against HDAC2; 3; and 11; and no activity to HDAC4; 5; 6; 7; and 8. Phase 1/2.,C(C1C=CC(=CC=1)CNC2N=C(C=CN=2)C3C=NC=CC=3)(=O)NC4C(=CC=CC=4)N,32.79,http://www.selleckchem.com/products/MGCD0103(Mocetinostat).html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E05,Erlotinib HCl (OSI-744),S1023,Erlotinib HCl (OSI-744),10,m,5,5,25,192895143,429.9,183319-69-9,hydrochloride,Autophagy;EGFR,Erlotinib HCl (OSI-744) is an EGFR inhibitor with IC50 of 2 nM; >1000-fold more sensitive for EGFR than human c-Src or v-Abl. Phase 3.,C1(=CC=CC(=C1)C#C)NC2(=NC=NC3=C2C=C(C(=C3)OCCOC)OCCOC)C.Cl,9.3,http://www.selleckchem.com/products/Erlotinib-Hydrochloride.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E06,Brivanib Alaninate (BMS-582664),S1138,Brivanib Alaninate (BMS-582664),10,m,6,5,25,192886515,441.46,649735-63-7,alaninate,VEGFR;FGFR,Brivanib alaninate (BMS-582664) is the prodrug of BMS-540215; an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM.,C12=C(C(=C(C=C1)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)OC([C@@H](N)C)=O)C)F)C=C(N2)C,199.34,http://www.selleckchem.com/products/Brivanib-alaninate.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E07,NVP-AEW541,S1034,NVP-AEW541,10,m,7,5,25,192898173,439.55,475489-16-8,free base,IGF-1R,NVP-AEW541 is a potent inhibitor of IGF-1R with IC50 of 86 nM; 27-fold greater selectivity for IGF-1R than InsR.,C1=CC(=CC(=C1)OCC2=CC=CC=C2)C3=CN(C4=C3C(=NC=N4)N)[C@@H]5C[C@@H](C5)CN6CCC6,200.2,http://www.selleckchem.com/products/NVP-AEW541.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E08,Barasertib (AZD1152-HQPA),S1147,Barasertib (AZD1152-HQPA),10,m,8,5,25,192897370,507.56,722544-51-6,free base,Aurora Kinase,AZD1152-HQPA (Barasertib) is a highly selective Aurora B inhibitor with IC50 of 0.37 nM; ~100 fold more selective for Aurora B over Aurora A.,C1(=CC=C2C(=C1)N=CN=C2NC3NN=C(C=3)CC(NC4=CC=CC(=C4)F)=O)OCCCN(CCO)CC,200.96,http://www.selleckchem.com/products/AZD1152-HQPA.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E09,Tandutinib (MLN518),S1043,Tandutinib (MLN518),10,m,9,5,25,192902857,562.7,387867-13-2,free base,FLT3,Tandutinib (MLN518; CT53518) is a potent FLT3 antagonist with IC50 of 0.22 _M; also inhibits PDGFR and c-Kit; 15 to 20-fold higher potency for FLT3 versus CSF-1R and >100-fold selectivity for the same target versus FGFR; EGFR and KDR. Phase 1/2.,C1=C(C(=CC2=C1N=CN=C2N3CCN(CC3)C(NC4=CC=C(C=C4)OC(C)C)=O)OC)OCCCN5CCCCC5,10.66,http://www.selleckchem.com/products/Tandutinib-(MLN518).html,Angiogenesis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E10,CEP-18770 (Delanzomib),S1157,CEP-18770 (Delanzomib),10,m,10,5,25,179617640,413.28,847499-27-8,free base,Proteasome,CEP-18770 is an orally active inhibitor of the chymotrypsin-like activity of proteasome with IC50 of 3.8 nM; with only marginal inhibition of the tryptic and peptidylglutamyl activities of the proteosome. Phase 1/2.,C([C@@H](C(C)C)B(O)O)NC([C@H]([C@@H](C)O)NC(=O)C1C=CC=C(N=1)C2C=CC=CC=2)=O,200.83,http://www.selleckchem.com/products/cep-18770.html,Proteases,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E11,Entinostat (MS-275),S1053,Entinostat (MS-275),10,m,11,5,25,194475003,376.41,209783-80-2,free base,HDAC,Entinostat (MS-275) strongly inhibits HDAC1 and HDAC3 with IC50 of 0.51 _M and 1.7 _M; compared with HDACs 4; 6; 8; and 10. Phase 1/2.,C1=C(C=CC(=C1)C(NC2=CC=CC=C2N)=O)CNC(OCC3=CN=CC=C3)=O,199.25,http://www.selleckchem.com/products/MS-275.html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E12,CP-724714,S1167,CP-724714,10,m,12,5,25,194475458,469.53,537705-08-1,free base,EGFR;HER2,CP-724;714 is a potent; selective inhibitor of HER2/ErbB2 with IC50 of 10 nM; >640-fold selectivity against EGFR; InsR; IRG-1R; PDGFR; VEGFR2; Abl; Src; c-Met etc. Phase 2.,C1(=CC=C2C(=C1)C(=NC=N2)NC3=CC=C(C(=C3)C)OC4=CC=C(N=C4)C)/C=C/CNC(COC)=O,200.2,http://www.selleckchem.com/products/CP-724714.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E13,SL-327,S1066,SL-327,10,m,13,5,25,194474982,335.35,305350-87-2,free base,MEK,SL327 is a selective inhibitor for MEK1/2 with IC50 of 0.18 _M/ 0.22 _M; no activity towards Erk1; MKK3; MKK4; c-JUN; PKC; PKA; or CamKII;capable of transport through the blood-brain barrier.,C1=CC=CC(=C1C(F)(F)F)/C(=C(/SC2=CC=C(C=C2)N)N)C#N,20.87,http://www.selleckchem.com/products/SL327.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E14,BIIB021,S1175,BIIB021,10,m,14,5,25,179701016,318.76,848695-25-0,free base,HSP (e.g. HSP90),BIIB021 is an orally available; fully synthetic small-molecule inhibitor of HSP90 with Ki and EC50 of 1.7 nM and 38 nM; respectively.,N1=C(N=C2C(=C1Cl)N=CN2CC3=C(C(=C(C=N3)C)OC)C)N,200.78,http://www.selleckchem.com/products/BIIB021.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E15,SB203580,S1076,SB203580,10,m,15,5,25,192887405,377.43,152121-47-6,free base,p38 MAPK,SB203580 is a p38 MAPK inhibitor with IC50 of 0.3-0.5 _M; 10-fold less sensitive to SAPK3(106T) and SAPK4(106T) and blocks PKB phosphorylation with IC50 of 3-5 _M. ,N1=CC=C(C=C1)C2=C(N=C(N2)C3=CC=C(C=C3)S(C)=O)C4=CC=C(C=C4)F,198.71,http://www.selleckchem.com/products/SB-203580.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E16,Ritonavir,S1185,Ritonavir,10,m,16,5,25,192949877,720.94,155213-67-5,free base,HIV Protease,Ritonavir is an antiretroviral drug which inhibits a particular liver enzyme that normally metabolizes protease inhibitors; cytochrome P450-3A4 (CYP3A4).,C1=CC=CC=C1C[C@@H]([C@H](C[C@H](CC2=CC=CC=C2)NC([C@@H](NC(N(CC3=CSC(=N3)C(C)C)C)=O)C(C)C)=O)O)NC(OCC4=CN=CS4)=O,138.71,http://www.selleckchem.com/products/Ritonavir.html,Proteases,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E17,NVP-ADW742,S1088,NVP-ADW742,10,m,17,5,25,192897703,453.58,475488-23-4,free base,IGF-1R,NVP-ADW742 is an IGF-1R inhibitor with IC50 of 0.17 _M; >16-fold more potent against IGF-1R than InsR;  little activity to HER2; PDGFR; VEGFR-2; Bcr-Abl and c-Kit.,C12=C(N=CN=C1N)N(C=C2C3=CC(=CC=C3)OCC4=CC=CC=C4)[C@@H]5C[C@H](C5)CN6CCCC6,22.05,http://www.selleckchem.com/products/NVP-ADW742.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E18,CUDC-101,S1194,CUDC-101,10,m,18,5,25,192927828,434.49,1012054-59-9,free base,HDAC;HER2;EGFR,CUDC-101 is a potent multi-targeted inhibitor against HDAC; EGFR and HER2 with IC50 of 4.4 nM; 2.4 nM; and 15.7 nM; and inhibits class I/II HDACs; but not class III; Sir-type HDACs. Phase 1.,C12=C(N=CN=C1NC3=CC(=CC=C3)C#C)C=C(C(=C2)OCCCCCCC(NO)=O)OC,46.03,http://www.selleckchem.com/products/CUDC-101.html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E19,Quisinostat (JNJ-26481585),S1096,Quisinostat (JNJ-26481585),10,m,19,5,25,179703477,394.476,875320-29-9,free base,HDAC,JNJ-26481585 is a novel second-generation HDAC inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM; modest potent to HDACs 2; 4; 10; and 11; greater than 30-fold selectivity against HDACs 3; 5; 8; and 9 and lowest potency to HDACs 6 and 7. Phase 2.,C1=CC=C2C(=C1)C(=CN2C)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO,169.02,http://www.selleckchem.com/products/JNJ-26481585.html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E20,Dutasteride,S1202,Dutasteride,10,m,20,5,25,192959700,528.53,164656-23-9,free base,5-alpha Reductase,Dutasteride is a dual 5-_ reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT).,C1C(N[C@]2([C@](C=1)([C@]3([C@@](CC2)([C@]4([C@](CC3)([C@@H](CC4)C(NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F)=O)C)[H])[H])[H])C)[H])=O,189.2,http://www.selleckchem.com/products/Dutasteride.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E21,LY294002,S1105,LY294002,10,m,21,5,25,192885541,307.34,154447-36-6,free base,Autophagy;PI3K,LY294002 is the first synthetic molecule known to inhibit PI3K_/_/_ with IC50 of 0.5 _M/0.57 _M/0.97 _M; respectively; more stable in solution than Wortmannin; and also blocks autophagosome formation.,C1=CC(=C2C(=C1)C(C=C(O2)N3CCOCC3)=O)C4=CC=CC=C4,198.48,http://www.selleckchem.com/products/LY294002.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,E22,Bendamustine HCl,S1212,Bendamustine HCl,10,m,22,5,25,192878692,394.72,3543-75-7,hydrochloride,Others,Bendamustine HCL is a DNA-damaging agent with IC50 of 50 _M.,C1(=C(C=C2C(=C1)N(C(=N2)CCCC(O)=O)C)N(CCCl)CCCl).Cl,200.14,http://www.selleckchem.com/products/Bendamustine-Hydrochloride.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F01,DMSO_F01,,DMSO_F01,,,1,6,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F02,DMSO_F02,,DMSO_F02,,,2,6,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F03,Topotecan HCl,S1231,Topotecan HCl,10,m,3,6,25,192958982,457.91,119413-54-6,hydrochloride,Topoisomerase,Topotecan (NSC 609699) is a topoisomerase I inhibitor for MCF-7 Luc cells and DU-145 Luc cells with IC50 of 13 nM and 2 nM; respectively.,C1(C=CC2C(C=1CN(C)C)=CC3=C(N=2)C4N(C3)C(C5=C(C=4)[C@](C(OC5)=O)(CC)O)=O)O.Cl,200.91,http://www.selleckchem.com/products/Topotecan-Hydrochloride.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F04,Lopinavir,S1380,Lopinavir,10,m,4,6,25,192943680,628.8,192725-17-0,free base,HIV Protease,Lopinavir is a potent HIV protease inhibitor with Ki of 1.3 pM.,C1=CC=C(C(=C1C)OCC(N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](N4CCCNC4=O)C(C)C)O)=O)C,200.38,http://www.selleckchem.com/products/Lopinavir.html,Proteases,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F05,Leflunomide,S1247,Leflunomide,10,m,5,6,25,192959089,270.21,75706-12-6,free base,Others,Leflunomide is an immunosuppressant agent. Its active metabolite is Teriflunomide.,C1(=CC=C(C=C1)C(F)(F)F)NC(C2C=NOC=2C)=O,199.84,http://www.selleckchem.com/products/Leflunomide.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F06,Oxcarbazepine,S1391,Oxcarbazepine,10,m,6,6,25,192949488,252.27,28721-07-5,free base,Sodium Channel,Oxcarbazepine inhibits the binding of [3H]BTX to sodium channels with IC50 of 160 _M and also inhibits the influx of 22Na+ into rat brain synaptosomes with IC50 about 100 _M.,N1(C2=C(C(CC3=C1C=CC=C3)=O)C=CC=C2)C(N)=O,27.75,http://www.selleckchem.com/products/Oxcarbazepine.html,Transmembrane Transporters,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F07,Posaconazole,S1257,Posaconazole,10,m,7,6,25,192959540,700.78,171228-49-2,free base,Others,Posaconazole is a sterol C14_ demethylase inhibitor with an IC50 of 0.25 nM.,C1(=CC=C(C=C1)N2CCN(CC2)C3=CC=C(C=C3)OC[C@@H]4CO[C@](C4)(C5=CC=C(C=C5F)F)CN6N=CN=C6)N7C(N(N=C7)[C@H]([C@H](C)O)CC)=O,199.78,http://www.selleckchem.com/products/Posaconazole.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F08,Tigecycline,S1403,Tigecycline,10,m,8,6,25,192866047,585.65,220620-09-7,free base,Others,Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation.,C1(=CC(=C(C2=C1C[C@@]3(C(C2=O)=C([C@]4([C@@](C3)([C@H](C(=C(C4=O)C(=O)N)O)N(C)C)[H])O)O)[H])O)NC(CNC(C)(C)C)=O)N(C)C,170.75,http://www.selleckchem.com/products/Tigecycline.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F09,Vemurafenib (PLX4032; RG7204),S1267,Vemurafenib (PLX4032; RG7204),10,m,9,6,25,192931780,489.92,918504-65-1,free base,Raf,Vemurafenib (PLX4032; RG7204) is a novel and potent inhibitor of B-RafV600E with IC50 of 31 nM.,C1(=CN=C2C(=C1)C(=CN2)C(=O)C3=C(C(=CC=C3F)NS(=O)(=O)CCC)F)C4=CC=C(C=C4)Cl,200.03,http://www.selleckchem.com/products/PLX-4032.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F10,Ranolazine 2HCl,S1425,Ranolazine 2HCl,10,m,10,6,25,192918132,500.46,95635-56-6,dihydrochloride,Calcium Channel,Ranolazine 2HCl; is an antianginal medication.,C1(=C(C(=C(C=C1)C)NC(=O)CN2CCN(CC2)CC(O)COC3=CC=CC=C3OC)C).Cl.Cl,199.82,http://www.selleckchem.com/products/Ranolazine-dihydrochloride.html,Transmembrane Transporters,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F11,Artemisinin,S1282,Artemisinin,10,m,11,6,25,192896935,282.33,63968-64-9,free base,Others,Artemisinin is a drug used to treat multi-drug resistant strains of falciparum malaria.,[C@@]12(O[C@@]3([C@]4([C@@](CC1)([C@H](CC[C@]4([C@@H](C(O3)=O)C)[H])C)[H])OO2)[H])C,201.89,http://www.selleckchem.com/products/Artemisinin.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F12,Tranilast,S1439,Tranilast,10,m,12,6,25,192881347,327.33,53902-12-8,free base,Others,Tranilast is an antiallergic compound.,C1(=C(C=CC(=C1)/C=C/C(NC2=CC=CC=C2C(O)=O)=O)OC)OC,201.63,http://www.selleckchem.com/products/Tranilast.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F13,Cetirizine DiHCl,S1291,Cetirizine DiHCl,10,m,13,6,25,192879795,461.81,83881-52-1,hydrochloride,Histamine Receptor,Cetirizine DiHCl is an antihistamine.,C1(=CC=CC=C1C(C2=CC=C(C=C2)Cl)N3CCN(CC3)CCOCC(O)=O).Cl.Cl,199.22,https://www.selleckchem.com/products/Cetirizine-Dihydrochloride.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F14,Ispinesib (SB-715992),S1452,Ispinesib (SB-715992),10,m,14,6,25,192918055,517.06,336113-53-2,free base,Kinesin,Ispinesib (SB-715992; CK0238273) is a potent; specific and reversible inhibitor of kinesin spindle protein (KSP) with Ki app of 1.7 nM; no inhibition to CENP-E; RabK6; MCAK; MKLP1; KHC or Kif1A. Phase 1/2.,C1=CC(=CC=C1)CN2C(C3=C(N=C2[C@H](N(CCCN)C(C4=CC=C(C=C4)C)=O)C(C)C)C=C(C=C3)Cl)=O,199.2,http://www.selleckchem.com/products/Ispinesib-mesilate(SB-715992).html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F15,Mercaptopurine (6-MP),S1305,Mercaptopurine (6-MP),10,m,15,6,25,192879944,152.18,50-44-2,free base,DNA/RNA Synthesis,Mercaptopurine is a widely used antileukemic agent and immunosuppressive drug that inhibits de novo purine synthesis through incorporation of thiopurine methyltransferase metabolites into DNA and RNA.,N1=CNC2=C(C1=S)NC=N2,197.13,http://www.selleckchem.com/products/Mercaptopurine.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F16,SP600125,S1460,SP600125,10,m,16,6,25,192944678,220.23,129-56-6,free base,JNK,SP600125 is a broad-spectrum JNK inhibitor for JNK1; JNK2 and JNK3 with IC50 of 40 nM; 40 nM and 90 nM; respectively; 10-fold greater selectivity against MKK4; 25-fold greater selectivity against MKK3; MKK6; PKB; and PKC_; and 100-fold selectivity against ERK2; p38; Chk1; EGFR etc.,C1C=CC2=C(C=1)C(C3=C4C2=NNC4=CC=C3)=O,199.79,http://www.selleckchem.com/products/SP600125.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F17,Etomidate,S1329,Etomidate,10,m,17,6,25,192886426,244.29,33125-97-2,free base,GABA Receptor,Etomidate is a GABAA receptors agonist at GABAA receptors.,N1(C(=CN=C1)C(OCC)=O)C(C)C2=CC=CC=C2,200.58,http://www.selleckchem.com/products/Etomidate.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F18,Safinamide Mesylate,S1472,Safinamide Mesylate,10,m,18,6,25,179748280,398.45,202825-46-5,mesylate,MAO,Safinamide Mesylate is mesylate salt of Safinamide; selectively and reversibly inhibits MAO-B with IC50 of 98 nM; exhibits 5918-fold selectivity against MAO-A. Phase 3.,C1(=CC=CC(=C1)COC2=CC=C(C=C2)CN[C@H](C(N)=O)C)F.CS(=O)(=O)O,200.78,http://www.selleckchem.com/products/Safinamide-mesilate.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F19,Ginkgolide B,S1343,Ginkgolide B,10,m,19,6,25,181366034,424.4,15291-77-7,free base,PAFR,Ginkgolide B is a PAFR antagonist with IC50 of 3.6 _M.,C123[C@@H]([C@]4([C@@]([C@]51O[C@]6(C2([C@@H](C[C@@H]3OC5=O)C(C)(C)C)[C@@H](C(O6)=O)O)[H])([C@H](C(O4)=O)C)O)[H])O,200.28,http://www.selleckchem.com/products/Ginkgolide-B.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F20,Iloperidone,S1483,Iloperidone,10,m,20,6,25,192880970,426.48,133454-47-4,free base,Others,Iloperidone is an atypical antipsychotic for the treatment of schizophrenia.,C1(=C(C=CC(=C1)C(C)=O)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,63.31,http://www.selleckchem.com/products/Iloperidone(Fanapt).html,Others,,L2300-Selleck-Cambridge-Cancer-Compound-Library
SelleckChem001,SP0135-A,F21,Loratadine,S1358,Loratadine,10,m,21,6,25,192885652,382.88,79794-75-5,free base,Histamine Receptor,Loratadine is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 _M.,C1CN(CCC1=C2C3=C(CCC4=C2C=CC(=C4)Cl)C=CC=N3)C(=O)OCC,44.4,http://www.selleckchem.com/products/Loratadine.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,F22,Fludarabine (Fludara),S1491,Fludarabine (Fludara),10,m,22,6,25,192885660,285.23,21679-14-1,Cancer,STAT; DNA/RNA Synthesis,Fludarabine (Fludara) is a purine analog and a chemotherapy drug with IC50 < 3 _M. Fludarabine is a STAT1 activation inhibitor which causes a specific depletion of STAT1 protein (and mRNA) but not of other STATs. Also a DNA synthesis inhibitor in vascular smooth muscle cells.,O1[C@@H]([C@H]([C@@H]([C@H]1N2C3=C(N=C2)C(=NC(=N3)F)N)O)O)CO,199.84,https://www.selleckchem.com/products/Fludarabine(Fludara).html,JAK/STAT,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G01,DMSO_G01,,DMSO_G01,,,1,7,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G02,DMSO_G02,,DMSO_G02,,,2,7,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G03,Bortezomib (PS-341),S1013,Bortezomib (PS-341),10,m,3,7,25,192904754,384.24,179324-69-7,free base,Proteasome,Bortezomib (PS-341) is a potent 20S proteasome inhibitor with Ki of 0.6 nM. It exhibits favorable selectivity towards tumor cells over normal cells.,C1=CN=CC(=N1)C(N[C@H](C(N[C@H](B(O)O)CC(C)C)=O)CC2=CC=CC=C2)=O,200.4,http://www.selleckchem.com/products/Bortezomib.html,Proteases,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G04,BMS-754807,S1124,BMS-754807,10,m,4,7,25,192886529,461.49,1001350-96-4,free base,IGF-1R;Trk receptor;c-Met,BMS-754807 is a potent and reversible inhibitor of IGF-1R/InsR with IC50 of 1.8 nM/1.7 nM; less potent to Met; Aurora A/B; TrkA/B and Ron; and shows little activity to Flt3; Lck; MK2; PKA; PKC etc. Phase 2.,C12N(N=C(N=C1NC3C=C(NN=3)C4CC4)N5CCC[C@]5(C)C(=O)NC6=CC=C(N=C6)F)C=CC=2,199.35,http://www.selleckchem.com/products/BMS-754807.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G05,Gefitinib (ZD1839),S1025,Gefitinib (ZD1839),10,m,5,7,25,192895108,446.9,184475-35-2,free base,EGFR,Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173; Tyr992; Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM; 37nM; 26 nM and 57 nM; respectively.,C1(=C(C=C2C(=C1)N=CN=C2NC3=CC=C(C(=C3)Cl)F)OCCCN4CCOCC4)OC,199.15,http://www.selleckchem.com/products/Gefitinib.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G06,ADL5859 HCl,S1139,ADL5859 HCl,10,m,6,7,25,179679520,428.95,850173-95-4,hydrochloride,Opioid Receptor,ADL5859 HCl is a _-opioid receptor agonist with Ki of 0.8 nM; selectivity against opioid receptor _; _; and weak inhibitory activity at the hERG channel. Phase 2.,C1(=CC=C2C(=C1O)C(=CC3(O2)CCNCC3)C4=CC=C(C=C4)C(=O)N(CC)CC).Cl,200.49,http://www.selleckchem.com/products/ADL-5859.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G07,Pazopanib HCl (GW786034 HCl),S1035,Pazopanib HCl (GW786034 HCl),10,m,7,7,25,194474269,473.98,635702-64-6,hydrochloride,VEGFR;PDGFR;c-Kit,Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1; VEGFR2; VEGFR3; PDGFR; FGFR; c-Kit and c-Fms with IC50 of 10 nM; 30 nM; 47 nM; 84 nM; 74 nM; 140 nM and 146 nM; respectively.,C1(=C(C(=CC(=C1)NC2=NC=CC(=N2)N(C3C=CC4C(C=3)=NN(C=4C)C)C)S(=O)(N)=O)C).Cl,35.87,http://www.selleckchem.com/products/Pazopanib-Hydrochloride.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G08,Docetaxel,S1148,Docetaxel,10,m,8,7,25,192926883,807.88,114977-28-5,free base,Microtubule Associated,Docetaxel; an analog of taxol; is an inhibitor of depolymerisation of microtubules by binding to stabilized microtubules.,C1=CC=CC=C1C(=O)O[C@H]2[C@]3(C[C@H](C(=C([C@H](C([C@]4([C@H](C[C@@H]5[C@](C42)(OC(C)=O)CO5)O)C)=O)O)C(C)(C)3)C)OC([C@@H]([C@H](C6=CC=CC=C6)NC(OC(C)(C)C)=O)O)=O)O,123.78,http://www.selleckchem.com/products/Docetaxel(Taxotere).html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G09,Temsirolimus (CCI-779; NSC 683864),S1044,Temsirolimus (CCI-779; NSC 683864),10,m,9,7,25,192886780,1030.29,162635-04-3,free base,mTOR,Temsirolimus (CCI-779) is a specific mTOR inhibitor with IC50 of 1.76 ?M in a cell-free assay.,[C@H]1(C[C@@H](CC[C@@H]1OC(C(CO)(CO)C)=O)C[C@H]([C@@H]2CC([C@@H](/C=C(/[C@H]([C@@H](OC)C([C@@H](C[C@@H](/C=C/C=C/C=C(/[C@H](C[C@]3(CC[C@H]([C@](C(C(N4[C@](C(O2)=O)(CCCC4)[H])=O)=O)(O3)O)C)[H])OC)C)C)C)=O)O)C)C)=O)C)OC,72.8,http://www.selleckchem.com/products/Temsirolimus.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G10,MK-8245,S1158,MK-8245,10,m,10,7,25,179678507,467.25,1030612-90-8,free base,Dehydrogenase,MK-8245 is an liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1; with anti-diabetic and anti-dyslipidemic efficacy. Phase 2.,N1N(N=NC=1C2=CC(=NO2)N3CCC(CC3)OC4C(=CC=C(C=4)F)Br)CC(=O)O,199.04,http://www.selleckchem.com/products/mk-8245.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G11,Enzastaurin (LY317615),S1055,Enzastaurin (LY317615),10,m,11,7,25,192886292,515.61,170364-57-5,free base,PKC,Enzastaurin (LY317615) is a potent PKC? selective inhibitor with IC50 of 6 nM in cell-free assays; 6- to 20-fold selectivity against PKC?; PKC? and PKC?. Phase 3.,C1=CC=C2C(=C1)C(=CN2C3CCN(CC3)CC4=NC=CC=C4)C5C(NC(C=5C6C7C(N(C=6)C)=CC=CC=7)=O)=O,58.18,http://www.selleckchem.com/products/Enzastaurin.html,TGF-beta/Smad,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G12,Valproic acid sodium salt (Sodium valproate),S1168,Valproic acid sodium salt (Sodium valproate),10,m,12,7,25,192873737,166.19,1069-66-5,free base,Autophagy;HDAC;GABA Receptor,"Valproic acid sodium salt (Sodium valproate) is a HDAC inhibitor with IC50 of 0.4 mM and also inhibits GABA-transaminase or succinic
SelleckChem001,SP0135-A,G13,SB431542,S1067,SB431542,10,m,13,7,25,192880810,384.39,301836-41-9,free base,TGF-beta/Smad,SB431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM; 100-fold more selective for ALK5 than p38 MAPK and other kinases.,C1=CC=CC(=N1)C2NC(=NC=2C3=CC4=C(C=C3)OCO4)C5=CC=C(C=C5)C(=O)N,200.32,http://www.selleckchem.com/products/SB-431542.html,TGF-beta/Smad,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G14,NPI-2358 (Plinabulin),S1176,NPI-2358 (Plinabulin),10,m,14,7,25,179736158,336.39,714272-27-2,,VDA,Plinabulin (NPI-2358) is a vascular disrupting agent (VDA) against tubulin-depolymerizing with IC50 of 9.8~18 nM in tumor cells. Phase 1/2.,C1=CC=CC(=C1)/C=C2\NC(/C(NC2=O)=C/C3=C(NC=N3)C(C)(C)C)=O,160.53,https://www.selleckchem.com/products/NPI-2358.html,Angiogenesis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G15,SB202190 (FHPI),S1077,SB202190 (FHPI),10,m,15,7,25,194471551,331.34,152121-30-7,free base,p38 MAPK,SB202190 (FHPI) is a potent p38 MAPK inhibitor targeting p38?/? with IC50 of 50 nM/100 nM in cell-free assays; sometimes used instead of SB 203580 to investigate potential roles for SAPK2a/p38 in vivo.,C1=C(C=CC(=C1)C2N=C(NC=2C3=CC=NC=C3)C4=CC=C(C=C4)O)F,199.19,http://www.selleckchem.com/products/SB-202190.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G16,BIBR 1532,S1186,BIBR 1532,10,m,16,7,25,192949516,331.36,321674-73-1,free base,Telomerase,BIBR 1532 is a potent; selective; non-competitive telomerase inhibitor with IC50 of 100 nM in a cell-free assay. No inhibition of DNA and RNA polymerases; including HIV reverse transcriptase were observed at concentrations vastly exceeding the IC50 for telomerase.,C1=CC=C2C(=C1)C=C(C=C2)/C(=C/C(NC3=C(C=CC=C3)C(=O)O)=O)C,199.18,http://www.selleckchem.com/products/BIBR1532.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G17,Refametinib (RDEA119; Bay 86-9766),S1089,Refametinib (RDEA119; Bay 86-9766),10,m,17,7,25,179703236,572.34,923032-37-5,Free Base,MEK,Refametinib (RDEA119; Bay 86-9766) is a potent; ATP non-competitive and highly selective inhibitor of MEK1 and MEK2 with IC50 of 19 nM and 47 nM; respectively.,C1(=C(C=C(C(=C1NC2=CC=C(C=C2F)I)F)F)OC)NS(C3(C[C@@H](CO)O)CC3)(=O)=O,174.72,www.selleckchem.com/products/refametinib-rdea119-bay86-9766.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G18,TAK-700 (Orteronel),S1195,TAK-700 (Orteronel),10,m,18,7,25,179678593,307.35,426219-18-3,free base,P450 (e.g. CYP17),TAK-700 (Orteronel) is a potent and highly selective human 17;20-lyase inhibitor with IC50 of 38 nM; exhibits >1000-fold selectivity over other CYPs (e.g. 11-hydroxylase and CYP3A4). Phase 3.,C1=C(C=C2C(=C1)C=C(C=C2)C3(C4N(CC3)C=NC=4)O)C(NC)=O,198.47,http://www.selleckchem.com/products/TAK-700.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G19,BTZ043 Racemate,S1097,BTZ043 Racemate,10,m,19,7,25,192950404,431.39,957217-65-1,Racemate,Others,BTZ043 racemate is a decaprenylphosphoryl-?-D-ribose 2'-epimerase (DprE1) inhibitor acting as a new antimycobacterial agent that kill Mycobacterium tuberculosis.,C1(=CC(=C2C(=C1)C(N=C(S2)N3CCC4(CC3)OCC(O4)C)=O)[N+](=O)[O-])C(F)(F)F,51,http://www.selleckchem.com/products/BTZ043.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G20,Melatonin,S1204,Melatonin,10,m,20,7,25,192866936,232.28,73-31-4,free base,Others,Melatonin is a hormone produced in the brain by the pineal gland from the amino acid tryptophan. Melatonin is a MT receptor agonist; used as a dietary supplement.,C1=CC(=CC2=C1NC=C2CCNC(=O)C)OC,202.34,http://www.selleckchem.com/products/Melatonin.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G21,OSU-03012 (AR-12),S1106,OSU-03012 (AR-12),10,m,21,7,25,192950003,460.45,742112-33-0,free base,PDK-1,OSU-03012 (AR-12) is a potent inhibitor of recombinant PDK-1(phosphoinositide-dependent kinase 1) with IC50 of 5 ?M in a cell-free assay and 2-fold increase in potency over OSU-02067.,C12=C(C=CC3=C1C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(CN)=O)C(F)(F)F)C=CC=C2,23.89,http://www.selleckchem.com/products/OSU-03012.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,G22,Nelarabine ,S1213,Nelarabine ,10,m,22,7,25,192878769,297.27,121032-29-9,free base,DNA/RNA Synthesis,Nelarabine is a purine nucleoside analog and DNA synthesis inhibitor with IC50 from 0.067-2.15 ?M in tumor cells.,N1C(=NC2=C(C=1OC)N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N,201.84,http://www.selleckchem.com/products/Arranon.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H01,DMSO_H01,,DMSO_H01,,,1,8,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H02,DMSO_H02,,DMSO_H02,,,2,8,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H03,2-Methoxyestradiol (2-MeOE2),S1233,2-Methoxyestradiol (2-MeOE2),10,m,3,8,25,192864244,302.41,362-07-2,free base,HIF,2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1? nuclear accumulation and HIF-transcriptional activity. Phase 2.,C1(=C(C=C2C(=C1)[C@]3([C@@](CC2)([C@]4([C@](CC3)([C@@H](CC4)O)C)[H])[H])[H])O)OC,201.71,http://www.selleckchem.com/products/2-Methoxyestradiol(2ME2).html,Angiogenesis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H04,Meropenem,S1381,Meropenem,10,m,4,8,25,192959386,383.46,96036-03-2,free base,Others,Meropenem is an ultra-broad spectrum injectable antibiotic.,N12C(C(C1=O)C(C)O)C(C(=C2C(O)=O)SC3CC(NC3)C(=O)N(C)C)C,200.8,http://www.selleckchem.com/products/Meropenem.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H05,Vinblastine,S1248,Vinblastine,10,m,5,8,25,192878969,810.97,865-21-4,free base,Microtubule Associated,Vinblastine sulfate inhibits microtubule formation and supresses nAChR activity with IC50 of 8.9 uM in a cell-free assay; used to treat certain kinds of cancer. Phase 2.,C123[C@]4(N(CC1)CC=C[C@@]4(CC)[C@@H]([C@]([C@@]2(N(C5C3=CC(=C(C=5)OC)[C@@]6(C7NC8=CC=CC=C8C=7CC[N@]9C[C@](C[C@](C6)([H])C9)(O)CC)C(OC)=O)C)[H])(O)C(=O)OC)OC(=O)C)[H],110,http://www.selleckchem.com/products/Vinblastine.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H06,Pelitinib (EKB-569),S1392,Pelitinib (EKB-569),10,m,6,8,25,192939506,467.92,257933-82-7,free base,EGFR,Pelitinib (EKB-569) is a potent irreversible EGFR inhibitor with IC50 of 38.5 nM. Phase2.,C1(=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(/C=C/CN(C)C)=O)OCC,27.78,http://www.selleckchem.com/products/Pelitinib.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H07,Prasugrel,S1258,Prasugrel,10,m,7,8,25,192944232,373.44,150322-43-3,free base,P2 Receptor,A novel platelet inhibitor. Prasugrel is a thienopyridine ADP receptor (P2Y12) antagonist; used for the reduction of thrombotic cardiovascular events.,C(C(C1C(=CC=CC=1)F)N2CCC3=C(C2)C=C(S3)OC(=O)C)(C4CC4)=O,80.33,http://www.selleckchem.com/products/Prasugrel.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H08,Trilostane,S1404,Trilostane,10,m,8,8,25,192958563,329.43,13647-35-3,free base,Dehydrogenase,Trilostane is an inhibitor of 3 _-hydroxysteroid dehydrogenase used in the treatment of Cushings syndrome.,C1(=C([C@@]2([C@]3([C@](C1)([C@]4([C@@](CC3)([C@]5([C@](CC4)([C@@H](CC5)O)C)[H])[H])[H])C)O2)[H])O)C#N,200.35,http://www.selleckchem.com/products/Trilostane.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H09,Acarbose,S1271,Acarbose,10,m,9,8,25,192864412,645.6,56180-94-0,free base,Others,Acarbose is an anti-diabetic drug used to treat type 2 diabetes mellitus and; in some countries; prediabetes.,[C@@H]1([C@@H]([C@H]([C@H](O[C@H]1C)O[C@H]2[C@@H]([C@H]([C@H](O[C@H]2CO)O[C@H]3[C@@H]([C@H]([C@@H](O[C@H]3CO)O)O)O)O)O)O)O)N[C@H]4C=C([C@H]([C@@H]([C@@H]4O)O)O)CO,199.81,http://www.selleckchem.com/products/Acarbose.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H10,Repaglinide,S1426,Repaglinide,10,m,10,8,25,179679466,452.59,135062-02-1,free base,Potassium Channel,Repaglinide is for the treatment of type II diabetes.,C1(=C(C=CC(=C1)CC(N[C@H](C2=CC=CC=C2N3CCCCC3)CC(C)C)=O)C(O)=O)OCC,201.06,http://www.selleckchem.com/products/Repaglinide.html,Transmembrane Transporters,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H11,Asenapine,S1283,Asenapine,10,m,11,8,25,192879856,401.84,85650-56-2,maleate,5-HT Receptor;Adrenergic Receptor,Asenapine inhibits adrenergic receptor (_1; _2A; _2B; _2C) with Ki of 0.25-1.2 nM and also inhibits 5-HT receptor (1A; 1B; 2A; 2B; 2C; 5A; 6; 7) with Ki of 0.03-4.0 nM. ,C12(=C([C@@]3([C@@](C4=C(O1)C=CC(=C4)Cl)(CN(C3)C)[H])[H])C=CC=C2).C(/C=C\C(=O)O)(=O)O,199.08,http://www.selleckchem.com/products/Asenapine.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H12,Venlafaxine,S1441,Venlafaxine,10,m,12,8,25,194475237,313.86,99300-78-4,hydrochloride,5-HT Receptor,Venlafaxine is an arylalkanolamine serotonin-norepinephrine reuptake inhibitor (SNRI).,C1(CCCCC1(C(CN(C)C)C2=CC=C(C=C2)OC)O).Cl,176.83,http://www.selleckchem.com/products/Venlafaxine-hydrochloride.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H13,Cilnidipine,S1293,Cilnidipine,10,m,13,8,25,192944899,492.52,132203-70-4,free base,Calcium Channel,Cilnidipine is a calcium channel blocker.,C1=CC=C(C=C1C2C(=C(NC(=C2C(OCCOC)=O)C)C)C(OC/C=C/C3=CC=CC=C3)=O)[N+](=O)[O-],201.01,http://www.selleckchem.com/products/Cilnidipine.html,Transmembrane Transporters,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H14,Tipifarnib ,S1453,Tipifarnib ,10,m,14,8,25,179711794,489.4,192185-72-1,free base,Transferase,Tipifarnib (R115777) is a potent and specific farnesyltransferase (FTase) inhibitor with IC50 of 0.6 nM; its anti-proliferative effects are most prominent in H-ras or N-ras mutant cells. Phase 3. ,C1=CC(=CC=C1[C@](C2=CN=CN2C)(C3=CC4=C(C=C3)N(C(C=C4C5=CC(=CC=C5)Cl)=O)C)N)Cl,28.61,http://www.selleckchem.com/products/Tipifarnib(R115777).html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H15,Streptozotocin (STZ),S1312,Streptozotocin (STZ),10,m,15,8,25,192879945,265.22,18883-66-4,free base,Others,Streptozotocin is a glucosamine-nitrosourea derivative; which is a methylating; carcinogenic; antibiotic and diabetes inducing agent.,[C@H]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(N(N=O)C)=O)O,199.83,http://www.selleckchem.com/products/Streptozotocin.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H16,AZD6482,S1462,AZD6482,10,m,16,8,25,192898761,408.45,1173900-33-8,free base,PI3K,AZD6482 is a PI3K_ inhibitor with IC50 of 10 nM; 8-; 87- and 109-fold more selective to PI3K_ than PI3K_; PI3K_ and PI3K_. Phase 1.,C(C1C(=CC=CC=1)N[C@H](C)C2=CC(=CN3C(C=C(N=C32)N4CCOCC4)=O)C)(=O)O,200.76,http://www.selleckchem.com/products/azd6482.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H17,Felbamate,S1330,Felbamate,10,m,17,8,25,192897005,238.24,25451-15-4,free base,Others,Felbamate (Felbatol) is an anticonvulsant drug used in the treatment of epilepsy.,C1=CC=CC=C1C(COC(N)=O)COC(N)=O,201.48,http://www.selleckchem.com/products/Felbamate.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H18,GSK429286A,S1474,GSK429286A,10,m,18,8,25,192962560,432.37,864082-47-3,free base,ROCK,GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM; respectively.,C1(CC(C(=C(N1)C)C(NC2=C(C=C3C(=C2)C=NN3)F)=O)C4=CC=C(C=C4)C(F)(F)F)=O,201.22,http://www.selleckchem.com/products/GSK429286A.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H19,Glimepiride,S1344,Glimepiride,10,m,19,8,25,192944339,490.62,93479-97-1,free base,DPP-4,Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 _g/kg.,C1=C(C=CC(=C1)S(NC(N[C@@H]2CC[C@H](CC2)C)=O)(=O)=O)CCNC(N3CC(=C(C3=O)CC)C)=O,22.42,http://www.selleckchem.com/products/Glimepiride.html,Proteases,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H20,MC1568,S1484,MC1568,10,m,20,8,25,192962908,314.31,852475-26-4,free base,HDAC,MC1568 is a selective HDAC inhibitor for maize HD1-A with IC50 of 100 nM. It is 34-fold more selective for HD1-A than HD1-B.,C1=CC(=CC(=C1)C(/C=C/C2=CN(C(=C2)/C=C/C(NO)=O)C)=O)F,41.36,http://www.selleckchem.com/products/MC1568.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H21,Losartan Potassium (DuP 753),S1359,Losartan Potassium (DuP 753),10,m,21,8,25,192879694,462.01,124750-99-8,potassium,RAAS,Losartan is an angiotensin II receptor antagonist; competes with the binding of angiotensin II to AT1 receptors with IC50 of 20 nM.,C1(=CC(=CC=C1C2=C(C=CC=C2)C3NN=NN=3)CN4C(=C(N=C4CCCC)Cl)CO).[K],199.13,http://www.selleckchem.com/products/losartan-potassium.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,H22,LY2228820,S1494,LY2228820,10,m,22,8,25,192896239,612.74,862507-23-1,mesylate,p38 MAPK,Ralimetinib (LY2228820) is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM; does not alter p38 MAPK activation. Phase 1/2.,CC(C1=NC(=C(N1)C2=NC3=C(C=C2)N=C(N3CC(C)(C)C)N)C4=CC=C(C=C4)F)(C)C.CS(=O)(=O)O.CS(=O)(=O)O,57.12,http://www.selleckchem.com/products/LY2228820.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I01,DMSO_I01,,DMSO_I01,,,1,9,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I02,DMSO_I02,,DMSO_I02,,,2,9,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I03,Bosutinib (SKI-606),S1014,Bosutinib (SKI-606),10,m,3,9,25,192902582,530.45,380843-75-4,free base,Src,Bosutinib (SKI-606) is a novel; dual Src/Abl inhibitor with IC50 of 1.2 nM and 1 nM; respectively.,N1=CC(=C(C2=CC(=C(C=C12)OCCCN3CCN(CC3)C)OC)NC4C(=CC(=C(C=4)OC)Cl)Cl)C#N,188.52,http://www.selleckchem.com/products/Bosutinib.html,Angiogenesis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I04,SRT1720,S1129,SRT1720,10,m,4,9,25,192922020,506.02,1001645-58-4,hydrochloride,Sirtuin,SRT1720 is a selective SIRT1 activator with EC50 of 0.16 _M; but is >230-fold less potent for SIRT2 and SIRT3. ,N1(=C(C=NC2=CC=CC=C12)C(=O)NC3C(=CC=CC=3)C4N=C5SC=C(N5C=4)CN6CCNCC6).Cl,75.1,http://www.selleckchem.com/products/SRT1720.html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I05,Imatinib Mesylate (STI571),S1026,Imatinib Mesylate (STI571),10,m,5,9,25,192895207,589.71,220127-57-1,mesylate,c-Kit;Bcr-Abl;PDGFR,Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib; which is a multi-target inhibitor of v-Abl; c-Kit and PDGFR with IC50 of 0.6 _M; 0.1 _M and 0.1 _M; respectively.,C1(=CC=C(C(=C1)NC2=NC=CC(=N2)C3=CC=CN=C3)C)NC(=O)C4(=CC=C(C=C4)CN5CCN(CC5)C).OS(C)(=O)=O,200.1,http://www.selleckchem.com/products/Imatinib-Mesylate.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I06,Andarine,S1140,Andarine,10,m,6,9,25,192949762,441.36,401900-40-1,free base,Androgen Receptor,Andarine is a selective non-steroidal androgen receptor (AR) agonist with Ki of 4 nM; tissue-selective for anabolic organs.,C([C@@](COC1C=CC(=CC=1)NC(=O)C)(C)O)(=O)NC2C=C(C(=CC=2)[N+](=O)[O-])C(F)(F)F,199.38,http://www.selleckchem.com/products/Andarine.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I07,PD0325901,S1036,PD0325901,10,m,7,9,25,192904538,482.19,391210-10-9,free base,MEK,PD0325901 (Mirdametinib) is selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM; roughly 500-fold more potent than CI-1040 on phosphorylation of ERK1 and ERK2. Phase 1/2.,C1=CC(=C(C(=C1C(=O)NOC[C@H](O)CO)NC2=CC=C(C=C2F)I)F)F,199.09,http://www.selleckchem.com/products/PD-0325901.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I08,Paclitaxel,S1150,Paclitaxel,10,m,8,9,25,179701030,853.91,33069-62-4,free base,Microtubule Associated;Autophagy,Paclitaxel is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells.,C1=CC=CC(=C1)C(=O)N[C@H]([C@H](C(O[C@H]2C[C@@]3(C(C(=C2C)[C@H](C(=O)[C@]4(C([C@]5([C@@H](C[C@H]4O)OC5)OC(C)=O)[C@@H]3OC(C6=CC=CC=C6)=O)C)OC(C)=O)(C)C)O)=O)O)C7=CC=CC=C7,200.26,http://www.selleckchem.com/products/Paclitaxel(Taxol).html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I09,Trichostatin A (TSA),S1045,Trichostatin A (TSA),10,m,9,9,25,179703535,302.4,58880-19-6,free base,HDAC,Trichostatin A (TSA) is an HDAC inhibitor with IC50 of ~1.8 nM  HDAC8 is the only known member of the HDAC-family that is not affected by TSA. Phase 3.,C1=C(C=CC(=C1)C([C@@H](/C=C(/C=C/C(NO)=O)C)C)=O)N(C)C,73.06,http://www.selleckchem.com/products/Trichostatin-A.html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I10,Ganetespib (STA-9090),S1159,Ganetespib (STA-9090),10,m,10,9,25,192885885,364.4,888216-25-9,free base,HSP (e.g. HSP90),Ganetespib is an HSP90 inhibitor with IC50 of 4 nM in OSA 8 cells; induces apoptosis of OSA cells while normal osteoblasts are not affected; active metabolite of STA-1474.,N1NC(N(C=1C2C(=CC(=C(C=2)C(C)C)O)O)C3=CC4C=CN(C(C=C3)=4)C)=O,109.77,http://www.selleckchem.com/products/ganetespib-sta-9090.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I11,AC480 (BMS-599626),S1056,AC480 (BMS-599626),10,m,11,9,25,192940471,567.01,714971-09-2,free base,HER2;EGFR,AC480 (BMS-599626) is a selective and efficacious inhibitor of HER1 and HER2 with IC50 of 20 nM and 30 nM; ~8-fold less potent to HER4; >100-fold to VEGFR2; c-Kit; Lck; MET etc. Phase 1.,C1(CN[C@@H](CO1)COC(NC2=CN3C(=C2C)C(=NC=N3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F)=O).Cl,212.99,http://www.selleckchem.com/products/BMS-599626.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I12,TGX-221,S1169,TGX-221,10,m,12,9,25,192928314,364.44,663619-89-4,free base,PI3K,TGX-221 is a p110?-specific inhibitor with IC50 of 5 nM in a cell-free assay; 1000-fold more selective for p110? than p110?.,C1=C(C=C(C2N1C(C=C(N=2)N3CCOCC3)=O)C(C)NC4=CC=CC=C4)C,32.93,http://www.selleckchem.com/products/TGX-221.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I13,Crizotinib (PF-02341066),S1068,Crizotinib (PF-02341066),10,m,13,9,25,192919531,450.34,877399-52-5,free base,c-Met;ALK,PF-2341066 (Crizotinib) is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nM; respectivley.,C1(=CC(=C(N=C1)N)O[C@@H](C2=C(C=CC(=C2Cl)F)Cl)C)C3=CN(N=C3)C4CCNCC4,19.98,http://www.selleckchem.com/products/PF-2341066.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I14,PD98059,S1177,PD98059,10,m,14,9,25,192878593,267.28,167869-21-8,free base,MEK,PD98059 is a non-ATP competitive MEK inhibitor with IC50 of 2 _M; specifically inhibits MEK-1-mediated activation of MAPK; does not directly inhibit ERK1 or ERK2.,C1=CC=C2C(=C1)C(C=C(O2)C3=CC=CC(=C3N)OC)=O,52.38,http://www.selleckchem.com/products/PD-98059.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I15,MK-2206 2HCl,S1078,MK-2206 2HCl,10,m,15,9,25,192887355,480.39,1032350-13-2,dihydrochloride,Akt,MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM; respectively; no inhibitory activities against 250 other protein kinases observed. Phase 2.,C1(=CC=CC=C1)C2(=C(N=C3C(=C2)C4N(C=C3)C(NN=4)=O)C5=CC=C(C=C5)C6(CCC6)N).Cl.Cl,199.84,http://www.selleckchem.com/products/MK-2206.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I16,Anastrozole,S1188,Anastrozole,10,m,16,9,25,192926903,293.37,120511-73-1,free base,Aromatase,Anastrozole is a third-generation nonsteroidal selective aromatase inhibitor. It may offer greater selectivity compared with other aromatase inhibitors; being without any intrinsic endocrine effects and with no apparent effect on the synthesis of adrenal steroids,C1=C(C=C(C=C1CN2C=NC=N2)C(C)(C)C#N)C(C)(C)C#N,201.11,http://www.selleckchem.com/products/Anastrozole.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I17,PCI-24781 (Abexinostat),S1090,PCI-24781 (Abexinostat),10,m,17,9,25,179702602,397.42,783355-60-2,free base,HDAC,PCI-24781 (Abexinostat) is a novel pan-HDAC inhibitor mostly targeting HDAC1 with Ki of 7 nM; modest potent to HDACs 2; 3; 6; and 10 and greater than 40-fold selectivity against HDAC8. Phase 1/2.,C1=CC=C2C(=C1)OC(=C2CN(C)C)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,201.3,http://www.selleckchem.com/products/PCI-24781.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I18,Exemestane,S1196,Exemestane,10,m,18,9,25,179702204,296.4,107868-30-4,free base,Aromatase,Exemestane is an aromatase inhibitor; inhibits human placental and rat ovarian aromatase with IC50 of 30 nM and 40 nM; respectively.,C1(C=C[C@@]2([C@@]3(CC[C@]4(C(CC[C@@]([C@](CC(C(=C1)2)=C)3[H])4[H])=O)C)[H])C)=O,182.19,http://www.selleckchem.com/products/Exemestane.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I19,Rucaparib (AG-014699;PF-01367338),S1098,Rucaparib (AG-014699;PF-01367338),10,m,19,9,25,194481848,421.36,459868-92-9,phosphate,PARP,Rucaparib (AG-014699; PF-01367338) is an inhibitor of PARP with Ki of 1.4 nM for PARP1; also showing binding affinity to eight other PARP domains. Phase 1/2.,C1(C2C=CC(=CC=2)CNC)(=C3C4=C(N1)C=C(C=C4C(NCC3)=O)F).P(=O)(O)(O)O,199.35,http://www.selleckchem.com/products/AG-014699.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I20,PIK-75,S1205,PIK-75,10,m,20,9,25,192878710,488.74,372196-77-5,hydrochloride,PI3K;DNA-PK,PIK-75 is a p110 alpha inhibitor with IC50 of 5.8 nM (200-fold more potently than p110_); isoform-specific mutants at Ser773; and also potently inhibits DNA-PK with IC50 of 2 nM.,C1(C(=CN2C(C=1)=NC=C2/C=N/N(S(C3=C(C=CC(=C3)[N+](=O)[O-])C)(=O)=O)C)Br).Cl,200.52,http://www.selleckchem.com/products/PIK-75-Hydrochloride.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I21,Danusertib (PHA-739358),S1107,Danusertib (PHA-739358),10,m,21,9,25,192885592,474.55,827318-97-8,free base,c-RET;FGFR;Bcr-Abl;Aurora Kinase,Danusertib (PHA-739358) is an Aurora kinase inhibitor for Aurora A/B/C with IC50 of 13 nM/79 nM/61 nM; modestly potent to Abl; TrkA; c-RET and FGFR1; and less potent to Lck; VEGFR2/3; c-Kit; CDK2; etc. Phase 2.,C1(=CC=CC=C1)[C@H](C(N2CC3=C(C2)C(=NN3)NC(=O)C4=CC=C(C=C4)N5CCN(CC5)C)=O)OC,200.19,http://www.selleckchem.com/products/PHA-739358(Danusertib).html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,I22,Bleomycin Sulfate,S1214,Bleomycin Sulfate,10,m,22,9,25,192879373,1512.62,9041-93-4,sulfate,DNA/RNA Synthesis,Bleomycin Sulfate is a glycopeptide antibiotic and an anticancer agent for squamous cell carcinomas (SCC) with IC50 of 4 nM in UT-SCC-19A cells.,S(=O)(=O)(O)[O-].[C@H](C(C1N=CNC=1)O[C@@H]2[C@@]([C@@H]([C@H]([C@H](O2)CO)O)O)(O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)OC(N)=O)O)[H])(C(N[C@H]([C@@H]([C@H](C(N[C@H]([C@@H](C)O)C(NCCC4=NC(=CS4)C5=NC(=CS5)C(NCCC[S+](C)C)=O)=O)=O)C)O)C)=O)NC(C6N=C(N=C(C=6C)N)[C@@H](NC[C@H](C(N)=O)N)CC(N)=O)=O,66.11,http://www.selleckchem.com/products/Bleomycin-sulfate.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J01,DMSO_J01,,DMSO_J01,,,1,10,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J02,DMSO_J02,,DMSO_J02,,,2,10,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J03,AG-1024 ,S1234,AG-1024 ,10,m,3,10,25,192877754,305.17,65678-07-1,free base,IGF-1R,AG-1024 (Tyrphostin) inhibits IGF-1R autophosphorylation with IC50 of 7 _M; is less potent to IR with IC50 of 57 _M and specifically distinguishes between InsR and IGF-1R (as compared to other tyrphostins).,C(C(C#N)=CC1C=C(C(=C(C=1)C(C)(C)C)O)Br)#N,199.89,http://www.selleckchem.com/products/ag-1024-tyrphostin.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J04,Mianserin HCl,S1382,Mianserin HCl,10,m,4,10,25,192877851,300.83,21535-47-7,hydrochloride,Histamine Receptor,Mianserin HCl is a psychoactive agent of the tetracyclic antidepressant. Mianserin is an potent antagonist of H1 histamine receptor and 5-HT serotonin receptors; used for the treatment of depression.,C12(N3C(C4=C(CC=1C=CC=C2)C=CC=C4)CN(CC3)C).Cl,199.45,http://www.selleckchem.com/products/Mianserin-hydrochloride.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J05,JNJ-7706621,S1249,JNJ-7706621,10,m,5,10,25,192866938,394.36,443797-96-4,free base,CDK;Aurora Kinase,JNJ-7706621 is pan-CDK inhibitor with the highest potency on CDK1/2 with IC50 of 9 nM/4 nM and showing >6-fold selectivity for CDK1/2 than CDK3/4/6. It also potently inhibits Aurora A/B and has no activity on Plk1 and Wee1.,C1(=CC=C(C=C1)NC2N=C(N(N=2)C(C3=C(C=CC=C3F)F)=O)N)S(N)(=O)=O,200.32,http://www.selleckchem.com/products/JNJ-7706621.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J06,Pirarubicin,S1393,Pirarubicin,10,m,6,10,25,181347563,627.64,72496-41-4,free base,Topoisomerase,Pirarubicin is an anthracycline agent. Pirarubicin is an anthracycline antibiotic; and also a DNA/RNA synthesis inhibitor by intercalating into DNA and interacts with topoisomerase II; used as an antineoplastic agent.,[C@@H]1([C@H]([C@H](C[C@@H](O1)O[C@@]2(C3=C(C[C@](C2)(C(CO)=O)O)C(=C4C(=C3O)C(C5=C(C4=O)C=CC=C5OC)=O)O)[H])N)O[C@H]6OCCCC6)C,159.33,http://www.selleckchem.com/products/Pirarubicin.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J07,Ramelteon,S1259,Ramelteon,10,m,7,10,25,192917460,259.34,196597-26-9,free base,MT Receptor,Ramelteon is a novel melatonin receptor agonist for human MT1 and MT2 receptors and chick forebrain melatonin receptors with Ki of 14 pM; 112 pM and 23.1 pM; respectively.,C1=C2C(=C3C(=C1)CC[C@H]3CCNC(CC)=O)CCO2,200.51,http://www.selleckchem.com/products/Ramelteon.html,GPCR & G Protein,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J08,Vecuronium Bromide,S1405,Vecuronium Bromide,10,m,8,10,25,192866103,637.73,50700-72-6,bromide,Others,Vecuronium Bromide is a muscle relaxant in the category of non-depolarizing blocking agents. Used for skeletal muscle relaxation during surgery.,C1(CCN(CC1)[C@@H]2[C@H](C[C@]3([C@](C2)([C@]4([C@@](CC3)([C@]5([C@](CC4)([C@@H]([C@H](C5)[N+]6(CCCCC6)C)OC(C)=O)C)[H])[H])[H])C)[H])OC(C)=O).[Br-],200.71,http://www.selleckchem.com/products/Vecuronium-Bromide.html#,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J09,BX-795,S1274,BX-795,10,m,9,10,25,192884803,591.47,702675-74-9,free base,I_B/IKK;PDK-1,BX795 is a potent and specific PDK1 inhibitor with IC50 of 6 nM; 140- and 1600-fold more selective for PDK1 than PKA and PKC; respectively. Meanwhile; in comparison to GSK3B more than 100-fold selectivity observed for PDK1.,N1(CCCC1)C(=O)NC2C=C(C=CC=2)NC3N=C(C(=CN=3)I)NCCCNC(C4=CC=CS4)=O,169.07,http://www.selleckchem.com/products/bx-795.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J10,Rolipram,S1430,Rolipram,10,m,10,10,25,192959073,275.34,61413-54-5,free base,PDE,Rolipram is a PDE4-inhibitor and an anti-inflammatory agent.Phase 1.,C1(=C(C=CC(=C1)C2CNC(C2)=O)OC)OC3CCCC3,199.75,http://www.selleckchem.com/products/Rolipram.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J11,Benazepril HCl,S1284,Benazepril HCl,10,m,11,10,25,192879765,460.95,86541-74-4,hydrochloride,RAAS,Benazepril HCl is a novel angiotensin I converting enzyme inhibitor; used primarily in treatment of hypertension.,N1(C([C@H](CCC2=C1C=CC=C2)N[C@H](C(OCC)=O)CCC3=CC=CC=C3)=O)CC(O)=O.Cl,199.59,http://www.selleckchem.com/products/Benazepril-hydrochloride.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J12,Voriconazole,S1442,Voriconazole,10,m,12,10,25,194475254,349.31,137234-62-9,free base,P450 (e.g. CYP17),Voriconazole is a new triazole derivative similar to fluconazole and itraconazole that acts by inhibiting fungal cytochrome P-450-dependent; 14-alpha-sterol demethylase-mediated synthesis of ergosterol.,C1=C(C(=CC(=C1)F)F)[C@@](CN2C=NC=N2)([C@H](C3=NC=NC=C3F)C)O,200.4,http://www.selleckchem.com/products/Voriconazole.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J13,Cilostazol,S1294,Cilostazol,10,m,13,10,25,192879933,369.46,73963-72-1,free base,PDE,Cilostazol is a potent cyclic nucleotide phosphodiesterase type 3 (PDE3) inhibitor with IC50 of 0.2 _M and inhibitor of adenosine uptake.,C1C(NC2=C(C1)C=C(C=C2)OCCCCC3N(N=NN=3)C4CCCCC4)=O,200.29,http://www.selleckchem.com/products/Cilostazol.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J14,PHA-680632,S1454,PHA-680632,10,m,14,10,25,192960048,501.62,398493-79-3,free base,Aurora Kinase,PHA-680632 is potent inhibitor of Aurora A; Aurora B and Aurora C with IC50 of 27 nM; 135 nM and 120 nM; respectively. It has 10- to 200-fold higher IC50 for FGFR1; FLT3; LCK; PLK1; STLK2; and VEGFR2/3. ,C1(=CC=C(C=C1)C(=O)NC2C3=C(NN=2)CN(C3)C(=O)NC4=C(C=CC=C4CC)CC)N5CCN(CC5)C,199.35,http://www.selleckchem.com/products/PHA-680632.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J15,Ki16425,S1315,Ki16425,10,m,15,10,25,181345314,474.96,355025-24-0,free base,LPA Receptor,Ki16425 is a competitive; potent and reversible antagonist to LPA1; LPA2 and LPA3 with Ki of 0.34 _M; 6.5 _M and 0.93 _M; respectively; shows no activity at LPA4; LPA5; LPA6.,C1=CC=CC(=C1Cl)C(C)OC(=O)NC2C(=NOC=2C3=CC=C(C=C3)CSCCC(O)=O)C,200.02,http://www.selleckchem.com/products/Ki16425.html,GPCR & G Protein,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J16,Moxifloxacin HCl,S1465,Moxifloxacin HCl,10,m,16,10,25,192958377,437.89,186826-86-8,hydrochloride,Topoisomerase,Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent.,C1(=C(C(=C2C(=C1)C(C(=CN2C3CC3)C(O)=O)=O)OC)N4C[C@@]5([C@](C4)(CCCN5)[H])[H])F.Cl,200.96,http://www.selleckchem.com/products/Moxifloxacin.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J17,Fluconazole,S1331,Fluconazole,10,m,17,10,25,192897301,306.27,86386-73-4,free base,Others,Fluconazole is a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections.,C1(=C(C=C(C=C1)F)F)C(CN2N=CN=C2)(CN3N=CN=C3)O,199.17,http://www.selleckchem.com/products/Fluconazole.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J18,Pimasertib (AS-703026),S1475,Pimasertib (AS-703026),10,m,18,10,25,192962583,431.2,1236699-92-5,free base,MEK,Pimasertib (AS-703026) is a highly selective; potent; ATP non-competitive allosteric inhibitor of MEK1/2 with IC50 of 5 nM-2 ?M in MM cell lines. Phase 2,C1=C(C=CC(=C1F)NC2=CN=CC=C2C(NC[C@@H](CO)O)=O)I,199.44,http://www.selleckchem.com/products/AS703026.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J19,Ivermectin,S1351,Ivermectin,10,m,19,10,25,192896851,875.09,70288-86-7,free base,Others,Ivermectin is a broad-spectrum antiparasitic medication.,[C@]12([C@]3([C@@H](C(=C[C@@]1(C(O[C@@H]4C[C@]5(O[C@@](C4)(C/C=C(/[C@H]([C@H](/C=C/C=C/2CO3)C)O[C@]6(C[C@@H]([C@H]([C@@H](O6)C)O[C@]7(C[C@@H]([C@H]([C@@H](O7)C)O)OC)[H])OC)[H])C)[H])O[C@@]([C@H](CC5)C)([C@@H](C)CC)[H])=O)[H])C)O)[H])O,199.98,http://www.selleckchem.com/products/Ivermectin.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J20,HMN-214,S1485,HMN-214,10,m,20,10,25,192962901,424.47,173529-46-9,free base,PLK,HMN-214 is a prodrug of HMN-176; which alters the cellular spatial orientation of Plk1.,C1=CC=CC(=C1N(S(C2=CC=C(C=C2)OC)(=O)=O)C(C)=O)/C=C/C3=CC=[N+](C=C3)[O-],28.27,http://www.selleckchem.com/products/HMN-214.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J21,GSK1059615,S1360,GSK1059615,10,m,21,10,25,192879621,333.36,958852-01-2,free base,PI3K;mTOR,GSK1059615 is a dual inhibitor of PI3K?/?/?/? (reversible) and mTOR with IC50 of 0.4 nM/0.6 nM/2 nM/5 nM and 12 nM; respectively. Phase 1.,C1(=CC=C2C(=C1)C(=CC=N2)C3=CC=NC=C3)/C=C4/C(NC(S4)=O)=O,6,http://www.selleckchem.com/products/GSK1059615.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,J22,Pralatrexate ,S1497,Pralatrexate ,10,m,22,10,25,192899097,477.47,146464-95-1,free base,DHFR,Pralatrexate is an antifolate; and structurally a folate analog. Its IC50 is < 300 nM in some cell lines.,N1=C(N=C2C(=C1N)N=C(C=N2)CC(C3=CC=C(C=C3)C(N[C@@H](CCC(O)=O)C(=O)O)=O)CC#C)N,58.64,http://www.selleckchem.com/products/Pralatrexate(Folotyn).html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K01,DMSO_K01,,DMSO_K01,,,1,11,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K02,DMSO_K02,,DMSO_K02,,,2,11,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K03,Cediranib (AZD2171),S1017,Cediranib (AZD2171),10,m,3,11,25,192940042,450.51,288383-20-0,free base,VEGFR,Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM; also inhibits Flt1/4 with IC50 of 5 nM/?3 nM; similar activity against c-Kit and PDGFR?; 36-; 110-fold and >1000-fold selective more for VEGFR than PDGFR-?; CSF-1R and Flt3 in HUVEC cells. Phase 3.,C1(=C(C=C2C(=C1)C(=NC=N2)OC3=C(C4=C(C=C3)NC(=C4)C)F)OCCCN5CCCC5)OC,199.77,http://www.selleckchem.com/products/Cediranib.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K04,YM155 (Sepantronium Bromide),S1130,YM155 (Sepantronium Bromide),10,m,4,11,25,192880104,443.29,781661-94-7,bromide,Survivin,YM155 (Sepantronium Bromide) is a potent survivin suppressant by inhibiting Survivin promoter activity with IC50 of 0.54 nM in HeLa-SURP-luc and CHO-SV40-luc cells; does not significantly inhibit SV40 promoter activity; but is observed to slightly inhibit the interaction of Survivin with XIAP. Phase 2.,C1(=CC=C2C(=C1)C(C3=C(C2=O)N(C(=N3CC4=NC=CN=C4)C)CCOC)=O).[Br-],124.07,http://www.selleckchem.com/products/YM155.html,Apoptosis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K05,Lapatinib (GW-572016) Ditosylate,S1028,Lapatinib (GW-572016) Ditosylate,10,m,5,11,25,179703304,925.46,388082-77-7,ditosylat,HER2;EGFR,Lapatinib Ditosylate (GW572016; GW2016) is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM; respectively.,C1(=C(C=C2C(=C1)N=CN=C2NC3=CC=C(C(=C3)Cl)OCC4=CC=CC(=C4)F)C5OC(=CC=5)CNCCS(=O)(C)=O).C6(=C(C=CC(=C6)S(O)(=O)=O)C).C7=C(C=CC(=C7)S(O)(=O)=O)C,199.9,http://www.selleckchem.com/products/Lapatinib-Ditosylate.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K06,17-AAG (Tanespimycin),S1141,17-AAG (Tanespimycin),10,m,6,11,25,192949907,585.69,75747-14-7,free base,HSP (e.g. HSP90),17-AAG is a potent HSP90 inhibitor with IC50 of 5 nM; having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells.,C1(=C2C(C(=CC1=O)NC(C(=C\C=C/[C@@H]([C@H](/C(=C/[C@@H]([C@H]([C@H](C[C@@H](C2)C)OC)O)C)C)OC(=O)N)OC)/C)=O)=O)NCC=C,199.76,http://www.selleckchem.com/products/17-AAG(Geldanamycin).html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K07,PI-103,S1038,PI-103,10,m,7,11,25,179703544,348.36,371935-74-9,free base,PI3K;Autophagy;DNA-PK;mTOR,PI-103 is a multi-targeted PI3K inhibitor for p110?/?/?/? with IC50 of 2 nM/3 nM/3 nM/15 nM in cell-free assays; less potent to mTOR/DNA-PK with IC50 of 30 nM/23 nM.,C12=C(N=C(N=C1N3CCOCC3)C4=CC=CC(=C4)O)C5=C(O2)N=CC=C5,68.89,http://www.selleckchem.com/products/PI-103.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K08,PLX-4720,S1152,PLX-4720,10,m,8,11,25,192886262,413.83,918505-84-7,free base,Raf,PLX4720 is a potent and selective inhibitor of B-RafV600E with IC50 of 13 nM; equally potent to c-Raf-1(Y340D and Y341D mutations); 10-fold selectivity for B-RafV600E than wild-type B-Raf.,C1(=CN=C2C(=C1)C(=CN2)C(=O)C3=C(C(=CC=C3F)NS(=O)(=O)CCC)F)Cl,200.57,http://www.selleckchem.com/products/PLX-4720.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K09,Vandetanib (ZD6474),S1046,Vandetanib (ZD6474),10,m,9,11,25,192903875,475.35,443913-73-3,free base,VEGFR,Vandetanib (ZD6474) is a potent inhibitor of VEGFR2 with IC50 of 40 nM.,C12=C(C(=NC=N1)NC3=C(C=C(C=C3)Br)F)C=C(C(=C2)OCC4CCN(CC4)C)OC,79.94,http://www.selleckchem.com/products/Vandetanib.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K10,PA-824,S1162,PA-824,10,m,10,11,25,179764806,359.26,187235-37-6,free base,Others,PA-824 is an anti-tuberculosis drug for tuberculosis with MIC less than 2.8 ?M.Phase 2.,O1C2N(C[C@@H](C1)OCC3C=CC(=CC=3)OC(F)(F)F)C=C(N=2)[N+](=O)[O-],200.41,http://www.selleckchem.com/products/pa-824.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K11,Obatoclax Mesylate (GX15-070),S1057,Obatoclax Mesylate (GX15-070),10,m,11,11,25,192886814,413.49,803712-79-0,mesylate,Bcl-2;Autophagy,Obatoclax Mesylate (GX15-070) is an antagonist of Bcl-2 with Ki of 0.22 ?M in a cell-free assay; can assist in overcoming MCL-1 mediated resistance to apoptosis. Phase 3.,C1(=CC=C2C(=C1)C=C(N2)C3C=C(/C(N=3)=C/C4=C(C=C(N4)C)C)OC).CS(=O)(=O)O,200.73,http://www.selleckchem.com/products/Obatoclax-Mesylate.html,Apoptosis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K12,WZ3146,S1170,WZ3146,10,m,12,11,25,192879447,464.95,1214265-56-1,free base,EGFR,WZ3146 is a mutant-selective irreversible inhibitor of EGFR(L858R) and EGFR(E746_A750) with IC50 of 2 nM and 2 nM; does not inhibit ERBB2 phosphorylation (T798I).,C1(=CC=C(C=C1)NC2=NC=C(C(=N2)OC3=CC(=CC=C3)NC(C=C)=O)Cl)N4CCN(CC4)C,200.02,http://www.selleckchem.com/products/WZ3146.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K13,AUY922 (NVP-AUY922),S1069,AUY922 (NVP-AUY922),10,m,13,11,25,192886837,465.54,747412-49-3,free base,HSP (e.g. HSP90),Luminespib (AUY-922; NVP-AUY922) is a highly potent HSP90 inhibitor for HSP90?/? with IC50 of 13 nM /21 nM in cell-free assays; weaker potency against the HSP90 family members GRP94 and TRAP-1; exhibits the tightest binding of any small-molecule HSP90 ligand. Phase 2.,C1(=CC(=C(C=C1C2=C(C(=NO2)C(=O)NCC)C3=CC=C(C=C3)CN4CCOCC4)C(C)C)O)O,199.77,http://www.selleckchem.com/products/NVP-AUY922.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K14,Regorafenib (BAY 73-4506),S1178,Regorafenib (BAY 73-4506),10,m,14,11,25,192928226,482.82,755037-03-7,free base,c-RET;VEGFR,Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1; VEGFR2; VEGFR3; PDGFR_; Kit; RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM; 22 nM; 7 nM; 1.5 nM and 2.5 nM; respectively.,C1=NC(=CC(=C1)OC2=CC(=C(C=C2)NC(NC3=CC=C(C(=C3)C(F)(F)F)Cl)=O)F)C(=O)NC,200.9,http://www.selleckchem.com/products/BAY-73-4506.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K15,SU11274,S1080,SU11274,10,m,15,11,25,194486697,568.09,658084-23-2,free base,c-Met,SU11274 is a selective Met inhibitor with IC50 of 10 nM in cell-free assays; no effects on PGDFR?; EGFR or Tie2.,C1(=CC=CC(=C1)N(C)S(C2=CC3=C(C=C2)NC(C/3=C/C4NC(=C(C=4C)C(N5CCN(CC5)C)=O)C)=O)(=O)=O)Cl,161.95,http://www.selleckchem.com/products/SU11274.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K16,Aprepitant,S1189,Aprepitant,10,m,16,11,25,192928775,534.43,170729-80-3,free base,Substance P,Aprepitant is a potent and selective neurokinin-1 receptor antagonist.,N1NC(NC=1CN2[C@H]([C@H](OCC2)O[C@@H](C)C3C=C(C=C(C=3)C(F)(F)F)C(F)(F)F)C4C=CC(=CC=4)F)=O,200.21,http://www.selleckchem.com/products/Aprepitant.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K17,OSI-906 (Linsitinib),S1091,OSI-906 (Linsitinib),10,m,17,11,25,179703238,421.49,867160-71-2,free base,IGF-1R,OSI-906 (Linsitinib) is a selective inhibitor of IGF-1R with IC50 of 35 nM; modestly potent to InsR with IC50 of 75 nM; and no activity towards Abl; ALK; BTK; EGFR; FGFR1/2; PKA etc. Phase 3.,C1=C(C=C2C(=C1)C=CC(=N2)C3=CC=CC=C3)C4=C5N(C(=N4)[C@H]6C[C@@](C6)(C)O)C=CN=C5N,199.29,http://www.selleckchem.com/products/OSI-906.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K18,Finasteride,S1197,Finasteride,10,m,18,11,25,192958979,372.54,98319-26-7,free base,5-alpha Reductase,Finasteride is a potent; reversible inhibitor of the rat type 1 5 alpha-reductase with Ki of 10.2 nM; used in the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).,C1C(N[C@]2([C@](C=1)([C@]3([C@@](CC2)([C@]4([C@](CC3)([C@@H](CC4)C(NC(C)(C)C)=O)C)[H])[H])[H])C)[H])=O,201.32,http://www.selleckchem.com/products/Finasteride.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K19,MLN8054,S1100,MLN8054,10,m,19,11,25,192886156,476.86,869363-13-3,free base,Aurora Kinase,MLN8054 is a potent and selective inhibitor of Aurora A with IC50 of 4 nM. It is more than 40-fold selective for Aurora A than Aurora B. Phase 1.,C1=C(C=C2C(=C1)C3=C(CN=C2C4=C(C=CC=C4F)F)C=NC(=N3)NC5=CC=C(C=C5)C(=O)O)Cl,199.22,http://www.selleckchem.com/products/MLN8054.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K20,Bisoprolol fumarate,S1206,Bisoprolol fumarate,10,m,20,11,25,179701993,441.52,104344-23-2,free base,Adrenergic Receptor,Bisoprolol fumarate is a selective type ?1 adrenergic receptor blocker.,C1(=C(C=CC(=C1)OCC(O)CNC(C)C)COCCOC(C)C).OC(/C=C/C(O)=O)=O,199.31,http://www.selleckchem.com/products/Bisoprolol-Fumarate.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K21,BI 2536,S1109,BI 2536,10,m,21,11,25,192886145,521.66,755038-02-9,free base,PLK,BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM. It shows 4- and 11-fold greater selectivity against Plk2 and Plk3. Phase 2.,C1(=CC=C(C(=C1)OC)NC2=NC=C3C(=N2)N([C@@H](C(N3C)=O)CC)C4CCCC4)C(NC5CCN(CC5)C)=O,40.26,http://www.selleckchem.com/products/BI-2536.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,K22,PFI-1 (PF-6405761),S1216,PFI-1 (PF-6405761),10,m,22,11,25,192922120,347.39,1403764-72-6,free base,Epigenetic Reader Domain,PFI-1 is a highly selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 ?M and for BRD2 with IC50 of 98 nM in a cell-free assay.,C1(=CC=C2C(=C1)CN(C(N2)=O)C)NS(=O)(=O)C3=C(C=CC=C3)OC,198.62,http://www.selleckchem.com/products/pfl-1.html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L01,DMSO_L01,,DMSO_L01,,,1,12,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L02,DMSO_L02,,DMSO_L02,,,2,12,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L03,Letrozole,S1235,Letrozole,10,m,3,12,25,192959061,285.3,112809-51-5,free base,Aromatase,Letrozole is a third generation inhibitor ofaromatasewith IC50 of 0.07-20 nM in cell-free assays.It has no effect on the plasma levels of 17?-OH progesterone; thyroid-stimulating hormone (TSH); luteinizing hormone (LH); follicle-stimulating hormone (FSH); or androstenedione and does not affect normal urine electrolyte excretion or thyroid function in clinical studies.,C1=CC(=CC=C1C(N2N=CN=C2)C3=CC=C(C=C3)C#N)C#N,199.79,http://www.selleckchem.com/products/Letrozole.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L04,Mosapride Citrate,S1385,Mosapride Citrate,10,m,4,12,25,192877890,614.02,112885-42-4,citrate,5-HT Receptor,Mosapride Citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.,C1(=C(C=C(C(=C1)C(NCC2OCCN(C2)CC3=CC=C(C=C3)F)=O)OCC)N)Cl.OC(CC(CC(O)=O)(C(=O)O)O)=O,146.58,http://www.selleckchem.com/products/Mosapride-citrate.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L05,Enzalutamide (MDV3100),S1250,Enzalutamide (MDV3100),10,m,5,12,25,192931279,464.44,915087-33-1,free base,Androgen Receptor,Enzalutamide (MDV3100) is an androgen-receptor (AR) antagonist with IC50 of 36 nM.,C1(=C(C=CC(=C1)N2C(N(C(C2(C)C)=O)C3=CC=C(C(=C3)C(F)(F)F)C#N)=S)C(NC)=O)F,198.09,http://www.selleckchem.com/products/MDV3100.html,Endocrinology & Hormones,,L2300-Selleck-Cambridge-Cancer-Compound-Library
SelleckChem001,SP0135-A,L06,Pizotifen Malate,S1394,Pizotifen Malate,10,m,6,12,25,192886620,429.53,5189-11-7,malate,Others,Pizotifen Malate is a benzocycloheptane based agent used for recurrent migraine headaches.,C1(C2=C(CCC3=C1C=CC=C3)SC=C2)=C4(CCN(CC4)C).C(C(CC(=O)O)O)(=O)O,48.89,http://www.selleckchem.com/products/Pizotifen-malate.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L07,Cinacalcet HCl,S1260,Cinacalcet HCl,10,m,7,12,25,192931799,393.87,364782-34-3,hydrochloride,CaSR,Cinacalcet HCl represents a new class of compounds for the treatment of hyperparathyroidism.,C1(=C(C=C(C=C1)CCCN[C@@](C2=CC=CC3=C2C=CC=C3)(C)[H])C(F)(F)F).Cl,200.57,http://www.selleckchem.com/products/Cinacalcet-hydrochloride.html,GPCR & G Protein,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L08,Bimatoprost,S1407,Bimatoprost,10,m,8,12,25,192866102,415.57,155206-00-1,free base,Others,Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension.,C1=CC=C(C=C1)CCC(O)/C=C/[C@@H]2[C@H]([C@H](C[C@H]2O)O)C/C=C\CCCC(=O)NCC,86.63,http://www.selleckchem.com/products/Bimatoprost.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L09,BX-912,S1275,BX-912,10,m,9,12,25,192878579,471.35,702674-56-4,free base,PDK-1,BX912 is a potent and specificPDK1inhibitor withIC50of 12 nM; 9- and 105- fold greater selectivity for PDK1 than PKA and PKC in cell-free assays; respectively. In comparison to GSK3?; selectivity for PDK1 is 600-fold.,N1(CCCC1)C(=O)NC2C=C(C=CC=2)NC3N=C(C(=CN=3)Br)NCCC4=CN=CN4,199.43,http://www.selleckchem.com/products/bx-912.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L10,Sildenafil Citrate,S1431,Sildenafil Citrate,10,m,10,12,25,192898402,666.7,171599-83-0,citrate,PDE,Sildenafil; a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5); is a well-tolerated and highly effective treatment for erectile dysfunction.,C1(=CC=C(C(=C1)C2=NC3=C(C(N2)=O)N(N=C3CCC)C)OCC)S(N4CCN(CC4)C)(=O)=O.C(C(O)=O)C(CC(O)=O)(O)C(O)=O,34.5,http://www.selleckchem.com/products/Sildenafil-citrate.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L11,Biperiden HCl,S1285,Biperiden HCl,10,m,11,12,25,192879769,347.92,1235-82-1,hydrochloride,AChR,Biperiden is an antiparkinsonian agent of the anticholinergic type.,C1(=CC(=CC=C1)C(CCN2CCCCC2)(C3CC4C=CC(C4)3)O).Cl,10,https://www.selleckchem.com/msds/Biperiden-hydrochloride-MSDS.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L12,Zileuton,S1443,Zileuton,10,m,12,12,25,192881374,236.29,111406-87-2,free base,Others,Zileuton is an orally active inhibitor of 5-lipoxygenase; and thus inhibits leukotrienes (LTB4; LTC4; LTD4; and LTE4) formation.,C1=CC=C2C(=C1)SC(=C2)C(N(O)C(N)=O)C,198.91,http://www.selleckchem.com/products/Zileuton.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L13,Epothilone A,S1297,Epothilone A,10,m,13,12,25,181365779,493.66,152044-53-6,free base,Microtubule Associated,Epothilone A is a Taxol-like microtubule-stabilizing agent with EC0.01 of 2 uM.,O1[C@@H]2CCC[C@@H]([C@@H]([C@H](C(C([C@@H](CC(O[C@H](C[C@H]12)/C(C)=C/C3N=C(SC=3)C)=O)O)(C)C)=O)C)O)C,200.54,http://www.selleckchem.com/products/Epothilone-A.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L14,Cilomilast,S1455,Cilomilast,10,m,14,12,25,181350684,343.42,153259-65-5,free base,PDE,Cilomilast is a potent PDE4 inhibitor with IC50 of about 110 nM; has anti-inflammatory activity and low central nervous system activity. Phase 3,C1(=C(C=CC(=C1)C2(CCC(CC2)(C(=O)O)[H])C#N)OC)OC3CCCC3,200.92,http://www.selleckchem.com/products/Cilomilast(SB-207499).html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L15,Costunolide,S1319,Costunolide,10,m,15,12,25,181366476,232.32,553-21-9,free base,Telomerase,Costunolide; a natural sesquiterpene compound with multiple biological activities; inhibits FPTase with IC50 of 20 _M; also inhibits telomerase with IC50 of 65-90 _M.,C1C/C(=C/[C@@H]2[C@@H](CC/C(=C/1)C)C(C(O2)=O)=C)C,202.31,http://www.selleckchem.com/products/Costunolide.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L16,Calcitriol,S1466,Calcitriol,10,m,16,12,25,192881578,416.64,32222-06-3,free base,Others,Calcitriol is the hormonally active form of vitamin D.,[C@@H]1(C[C@@H](C(/C(C1)=C\C=C2\[C@]3([C@](CCC2)([C@@H](CC3)[C@@H](CCCC(C)(C)O)C)C)[H])=C)O)O,199.21,http://www.selleckchem.com/products/Calcitriol-(Rocaltrol).html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L17,Flumazenil,S1332,Flumazenil,10,m,17,12,25,192884787,303.29,78755-81-4,free base,GABA Receptor,Flumazenil is a competitiveGABAA receptorantagonist; used in the treatment of benzodiazepine overdoses.,C1=C(C=C2C(=C1)N3C(CN(C2=O)C)=C(N=C3)C(=O)OCC)F,23.08,http://www.selleckchem.com/products/Flumazenil.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L18,SB525334,S1476,SB525334,10,m,18,12,25,192917491,343.42,356559-20-1,free base,TGF-beta/Smad,SB525334 is a potent and selective inhibitor of TGF_ receptor I (ALK5) with IC50 of 14.3 nM; is 4-fold less potent to ALK4 than ALK5 and inactive to ALK2; 3; and 6.,C1(=CC=C2C(=C1)N=CC=N2)C3NC(=NC=3C4=CC=CC(=N4)C)C(C)(C)C,200.92,http://www.selleckchem.com/products/SB-525334.html,TGF-beta/Smad,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L19,TG100-115,S1352,TG100-115,10,m,19,12,25,192944526,346.34,677297-51-7,free base,PI3K,TG100-115 is aPI3K?/?inhibitor withIC50of 83 nM/235 nM; with little effect on PI3K?/?. Phase 1/2.,C1(=C(N=C2C(=N1)C(=NC(=N2)N)N)C3=CC=CC(=C3)O)C4=CC(=CC=C4)O,25.99,http://www.selleckchem.com/products/TG100-115.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L20,AEE788 (NVP-AEE788),S1486,AEE788 (NVP-AEE788),10,m,20,12,25,192939852,440.58,497839-62-0,free base,HER2;VEGFR;EGFR,AEE788 (NVP-AEE788) is a potent inhibitor ofEGFRandHER2/ErbB2withIC50of 2 nM and 6 nM; less potent to VEGFR2/KDR; c-Abl; c-Src; and Flt-1; does not inhibit Ins-R; IGF-1R; PKC? and CDK1. Phase 1/2.,C1=NC(=C2C(=N1)NC(=C2)C3=CC=C(C=C3)CN4CCN(CC4)CC)N[C@@H](C5=CC=CC=C5)C,199.74,http://www.selleckchem.com/products/AEE788.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L21,MGCD-265,S1361,MGCD-265,10,m,21,12,25,192879580,517.6,875337-44-3,free base,Tie-2;VEGFR;c-Met,MGCD-265 is a potent; multi-target and ATP-competitive inhibitor of c-Met and VEGFR1/2/3 with IC50 of 1 nM; 3 nM/3 nM/4 nM; respectively; also inhibits Ron and Tie2. Phase 1/2.,C1(=CC=CC=C1)CC(NC(NC2=CC=C(C(=C2)F)OC3=C4C(=NC=C3)C=C(S4)C5N=CN(C=5)C)=S)=O,200.93,https://www.selleckchem.com/products/mgcd-265-analog.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,L22,Betamethasone ,S1500,Betamethasone ,10,m,22,12,25,192881314,392.46,378-44-9,free base,Others,Betamethasone is a glucocorticoid steroid with anti-inflammatory and immunosuppressive properties.,C1C(C=C2[C@](C=1)([C@]3([C@@](CC2)([C@]4([C@](C[C@H]3O)([C@@]([C@H](C4)C)(C(CO)=O)O)C)[H])[H])F)C)=O,201.29,http://www.selleckchem.com/products/Betamethasone-(Celestone).html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M01,DMSO_M01,,DMSO_M01,,,1,13,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M02,DMSO_M02,,DMSO_M02,,,2,13,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M03,Dovitinib (TKI-258; CHIR-258),S1018,Dovitinib (TKI-258; CHIR-258),10,m,3,13,25,179703326,392.43,405169-16-6,citrate,FGFR;FLT3;c-Kit;VEGFR;PDGFR,Dovitinib (TKI258; CHIR258) is a multitargeted RTK inhibitor; mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM; also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM; less potent to InsR; EGFR; c-Met; EphA2; Tie2; IGF-1R and HER2. Phase 4.,C1=CC=C(C2=C1NC(C(=C2N)C3NC4=C(N=3)C=CC(=C4)N5CCN(CC5)C)=O)F,76.45,http://www.selleckchem.com/products/CHIR-258.html,Angiogenesis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M04,INO-1001,S1132,INO-1001,10,m,4,13,25,192928198,136.15,3544-24-9,free base,PARP,INO-1001 is a potent inhibitor of PARP with IC50 of <50 nM in CHO cells and a mediator of oxidant-induced myocyte dysfunction during reperfusion. Phase 2.,C1=CC=C(C=C1C(=O)N)N,198.31,http://www.selleckchem.com/products/INO-1001.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M05,Lenalidomide (CC-5013),S1029,Lenalidomide (CC-5013),10,m,5,13,25,194474722,259.26,191732-72-6,free base,TNF-alpha,Lenalidomide (CC-5013) is a TNF-_ secretion inhibitor with IC50 of 13 nM.,C1=CC(=C2C(=C1)C(N(C2)C3C(NC(CC3)=O)=O)=O)N,200.57,https://www.selleckchem.com/products/lenalidomide-s1029.html,Apoptosis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M06,17-DMAG (Alvespimycin) HCl,S1142,17-DMAG (Alvespimycin) HCl,10,m,6,13,25,192950522,653.21,467214-21-7,hydrochloride,HSP (e.g. HSP90),Alvespimycin (17-DMAG) HCl is a potentHSP90inhibitor withIC50of 62 nM in a cell-free assay. Phase 2.,C1(=C2C(C(=CC1=O)NC(C(=C\C=C/[C@@H]([C@H](/C(=C/[C@@H]([C@H]([C@H](C[C@@H](C2)C)OC)O)C)C)OC(=O)N)OC)/C)=O)=O)NCCN(C)C.Cl,200.55,"http://www.selleckchem.com/products/17-DMAG,Hydrochloride-Salt.html",Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M07,Rapamycin (Sirolimus),S1039,Rapamycin (Sirolimus),10,m,7,13,25,192928171,914.18,53123-88-9,free base,Autophagy;mTOR,Rapamycin (Sirolimus; AY-22989; WY-090217) is a specific mTOR inhibitor with IC50 of ~0.1 nM.,[C@@H]1([C@@H](C[C@@H](CC1)C[C@H]([C@@H]2CC([C@@H](/C=C(\C)[C@H]([C@@H](C([C@@H](C[C@@H](/C=C/C=C/C=C(/[C@H](C[C@@H]3CC[C@H]([C@](C(C(N4CCCC[C@@H](C(O2)=O)4)=O)=O)(O3)O)C)OC)C)C)C)=O)OC)O)C)=O)C)OC)O,109.39,http://www.selleckchem.com/products/Rapamycin.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M08,Roscovitine (Seliciclib;CYC202),S1153,Roscovitine (Seliciclib;CYC202),10,m,8,13,25,194487330,354.45,186692-46-6,free base,CDK,Roscovitine (Seliciclib; CYC202) is a potent and selective CDK inhibitor for Cdc2; CDK2 and CDK5 with IC50 of 0.65 _M; 0.7 _M and 0.16 _M. It shows little effect on CDK4/6. Phase 2.,N1=C2C(=C(N=C1N[C@@H](CO)CC)NCC3=CC=CC=C3)N=CN2C(C)C,200.31,http://www.selleckchem.com/products/Roscovitine.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M09,Vorinostat (SAHA; MK0683),S1047,Vorinostat (SAHA; MK0683),10,m,9,13,25,192895129,264.3,149647-78-9,free base,Autophagy;HDAC,Vorinostat (suberoylanilide hydroxamic acid; SAHA) is an HDAC inhibitor with IC50 of ~10 nM.,C1=CC=CC(=C1)NC(=O)CCCCCCC(NO)=O,200.53,http://www.selleckchem.com/products/Vorinostat-(SAHA).html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M10,AT13387,S1163,AT13387,10,m,10,13,25,179678966,409.52,912999-49-6,free base,HSP (e.g. HSP90),Onalespib (AT13387) is a selective potent Hsp90 inhibitor with IC50 of 18 nM in A375 cells; displays a long duration of anti-tumor activity.,C(=O)(N1CC2C=CC(=CC(C1)=2)CN3CCN(CC3)C)C4C(=CC(=C(C=4)C(C)C)O)O,61.05,http://www.selleckchem.com/products/at13387.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M11,Olaparib (AZD2281; Ku-0059436),S1060,Olaparib (AZD2281; Ku-0059436),10,m,11,13,25,194486743,434.46,763113-22-0,free base,PARP,Olaparib (AZD2281; KU0059436) is a selective inhibitor of PARP1/2 with IC50 of 5 nM/1 nM; 300-times less effective against tankyrase-1. Phase 1/2.,C1=CC=CC2=C1C(=NNC2=O)CC3=CC(=C(C=C3)F)C(N4CCN(CC4)C(=O)C5CC5)=O,200.25,http://www.selleckchem.com/products/AZD2281(Olaparib).html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M12,CYC116,S1171,CYC116,10,m,12,13,25,192864223,368.46,693228-63-6,free base,Aurora Kinase;VEGFR,CYC116 is a potent inhibitor of Aurora A/B with Ki of 8.0 nM/9.2 nM; is less potent to VEGFR2 (Ki of 44 nM); with 50-fold greater potency than CDKs; not active against PKA; Akt/PKB; PKC; no effect on GSK-3_/_; CK2; Plk1 and SAPK2A. Phase 1.,C1(=NC=CC(=N1)C2SC(=NC=2C)N)NC3=CC=C(C=C3)N4CCOCC4,65.14,http://www.selleckchem.com/products/CYC116.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M13,PHA-665752,S1070,PHA-665752,10,m,13,13,25,194486615,641.61,477575-56-7,free base,c-Met,PHA-665752 is a potent; selective and ATP-competitive c-Met inhibitor with IC50 of 9 nM;  >50-fold selectivity for c-Met than RTKs or STKs.,C1=CC=C(C(=C1Cl)CS(C2=CC3=C(C=C2)NC(C/3=C/C4=C(C(=C(N4)C)C(N5[C@H](CCC5)CN6CCCC6)=O)C)=O)(=O)=O)Cl,199.5,http://www.selleckchem.com/products/PHA-665752.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M14,WZ8040,S1179,WZ8040,10,m,14,13,25,192879429,481.01,1214265-57-2,free base,EGFR,WZ8040 is a novel mutant-selective irreversible EGFRT790M inhibitor; does not inhibit ERBB2 phosphorylation (T798I).,C1(=CC=C(C=C1)NC2=NC=C(C(=N2)SC3=CC(=CC=C3)NC(C=C)=O)Cl)N4CCN(CC4)C,199.58,http://www.selleckchem.com/products/WZ8040.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M15,Vismodegib (GDC-0449),S1082,Vismodegib (GDC-0449),10,m,15,13,25,192887374,421.3,879085-55-9,free base,Hedgehog/Smoothened,Vismodegib (GDC-0449) is a potent; novel and specific hedgehog inhibitor with IC50 of 3 nM and also inhibits P-gp with IC50 of 3.0 _M.,C1(=C(C=C(C=C1)NC(C2=CC=C(C=C2Cl)S(C)(=O)=O)=O)C3=NC=CC=C3)Cl,199.38,http://www.selleckchem.com/products/GDC-0449.html,Stem Cells &  Wnt,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M16,Bicalutamide,S1190,Bicalutamide,10,m,16,13,25,192927883,430.37,90357-06-5,free base,Androgen Receptor,Bicalutamide is an androgen receptor (AR) antagonist with IC50 of 0.16 _M.,C(C(CS(=O)(=O)C1C=CC(=CC=1)F)(C)O)(=O)NC2C=C(C(=CC=2)C#N)C(F)(F)F,199.83,http://www.selleckchem.com/products/Bicalutamide(Casodex).html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M17,KU-55933 (ATM Kinase Inhibitor),S1092,KU-55933 (ATM Kinase Inhibitor),10,m,17,13,25,192897763,395.49,587871-26-9,free base,ATM/ATR,KU-55933 is a potent and specific ATM inhibitor with IC50/Ki of 12.9 nM/2.2 nM; and is highly selective for ATM as compared to DNA-PK; PI3K/PI4K; ATR and mTOR.,C1=CC=C2C(=C1)SC3=C(S2)C=CC=C3C4=CC(C=C(O4)N5CCOCC5)=O,83.44,http://www.selleckchem.com/products/KU-55933.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M18,Irinotecan,S1198,Irinotecan,10,m,18,13,25,192872128,586.68,97682-44-5,free base,Topoisomerase,Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 _M and 5.17 _M; respectively.,N1(CCCCC1)C2CCN(CC2)C(=O)OC3=CC4=C(C5=C(N=C(C=C3)4)C6=CC7=C(C(N(C5)6)=O)COC([C@@]7(O)CC)=O)CC,17,http://www.selleckchem.com/products/Irinotecan.html,DNA Damage,Product S1198 does not exist in selleck chem's website. The information here is for S2217 cas 136572-09-3. MW 677.18; DMSO solubility: 199.36; synonyms: CPT-11 HCl Trihydrate,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M19,Vatalanib (PTK787) 2HCl,S1101,Vatalanib (PTK787) 2HCl,10,m,19,13,25,194486581,419.73,212141-51-0,dihydrochloride,c-Kit;VEGFR,Vatalanib (PTK787) is an inhibitor of VEGFR2/KDR with IC50 of 37 nM; less potent against VEGFR1/Flt-1; 18-fold against VEGFR3/Flt-4. Phase 1/2.,C1(=CC=C2C(=C1)C(=NN=C2CC3=CC=NC=C3)NC4=CC=C(C=C4)Cl).Cl.Cl,202.51,"http://www.selleckchem.com/products/Vatalanib,Dihydrochloride-Salt.html",Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M20,Tivozanib (AV-951),S1207,Tivozanib (AV-951),10,m,20,13,25,192940324,454.86,475108-18-0,free base,VEGFR;PDGFR;c-Kit,Tivozanib (AV-951) is a potent and selective VEGFR inhibitor for VEGFR1/2/3 with IC50 of 30 nM/6.5 nM/15 nM; and also inhibits PDGFR and c-Kit; low activity observed against FGFR-1; Flt3; c-Met EGFR and IGF-1R. Phase 3.,C1(=CC=C(C(=C1)Cl)NC(=O)NC2C=C(ON=2)C)OC3=CC=NC4=C3C=C(C(=C4)OC)OC,43.97,http://www.selleckchem.com/products/AV-951.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M21,Varespladib (LY315920),S1110,Varespladib (LY315920),10,m,21,13,25,179679518,380.39,172732-68-2,free base,Phospholipase (e.g. PLA),LY315920 (Varespladib) is a potent and selective human non-pancreatic secretory phospholipase A2 (hnsPLA) inhibitor with IC50 of 7 nM;. Phase 3.,C1(N(C2=C(C=1C(C(N)=O)=O)C(=CC=C2)OCC(=O)O)CC3=CC=CC=C3)CC,199.79,http://www.selleckchem.com/products/LY315920(Varespladib).html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,M22,Clofarabine,S1218,Clofarabine,10,m,22,13,25,192959984,303.68,123318-82-1,free base,DNA/RNA Synthesis,Clofarabine inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase.,N1=C(N=C2C(=C1N)N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl,200.87,http://www.selleckchem.com/products/Clofarabine.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N01,DMSO_N01,,DMSO_N01,,,1,14,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N02,DMSO_N02,,DMSO_N02,,,2,14,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N03,Temozolomide,S1237,Temozolomide,10,m,3,14,25,179700968,194.15,85622-93-1,free base,Autophagy,Temozolomide is a monofunctional SN-1 alkylating agent that can modify nitrogen atoms in the DNA ring and the extracyclic oxygen group; chemically converted to MTIC and degrades to methyldiazonium cation; which transfers methyl groups to DNA at physiologic pH. A DNA damage inducer in L-1210 and L-1210/BCNU cells.,N1(N=NC2N(C1=O)C=NC=2C(N)=O)C,195.72,http://www.selleckchem.com/products/Methazolastone.html,Ubiquitin,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N04,Nafamostat Mesylate,S1386,Nafamostat Mesylate,10,m,4,14,25,192944482,539.58,82956-11-4,mesylate,Proteasome,Nafamostat mesilate is a syntheticserine proteaseinhibitor; used as an anticoagulant during hemodialysis.,C1(=CC=C(C=C1)NC(=N)N)C(=O)OC2(=CC3=C(C=C2)C=C(C=C3)C(=N)N).S(O)(C)(=O)=O.S(O)(C)(=O)=O,37.07,http://www.selleckchem.com/products/Nafamostat-mesylate.html,Proteases,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N05,Dienogest,S1251,Dienogest,10,m,5,14,25,194482539,311.42,65928-58-7,free base,Estrogen/progestogen Receptor,Dienogest is an orally active synthetic progesterone; used for contraception and the treatment of endometriosis.,C1(CCC2=C3CC[C@]4([C@](CC[C@@]([C@](CCC(=C1)2)3[H])4[H])(O)CC#N)C)=O,199.09,http://www.selleckchem.com/products/Dienogest.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N06,Resveratrol,S1396,Resveratrol,10,m,6,14,25,192885670,228.24,501-36-0,free base,Sirtuin;Autophagy,Resveratrol has a wide spectrum of targets including cyclooxygenases(i.e.COX; IC50=1.1 ?M); lipooxygenases?LOX; IC50=2.7 ?M?; kinases; sirtuins and other proteins. It has anti-cancer; anti-inflammatory; blood-sugar-lowering and other beneficial cardiovascular effects.,C1(=CC=C(C=C1)/C=C/C2=CC(=CC(=C2)O)O)O,197.16,http://www.selleckchem.com/products/Resveratrol.html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N07,Celecoxib,S1261,Celecoxib,10,m,7,14,25,192878953,381.37,169590-42-5,free base,COX,Celecoxib is a selective COX-2 inhibitor with IC50 of 40 nM.,C1(=CC=C(C=C1)S(N)(=O)=O)N2C(=CC(=N2)C(F)(F)F)C3=CC=C(C=C3)C,199.28,http://www.selleckchem.com/products/Celecoxib.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N08,Linezolid,S1408,Linezolid,10,m,8,14,25,192959375,337.35,165800-03-3,free base,Others,Linezolid is a synthetic antibiotic used for the treatment of serious infections. ,C1=C(C(=CC(=C1)N2C[C@@H](OC2=O)CNC(C)=O)F)N3CCOCC3,201.57,http://www.selleckchem.com/products/Linezolid(Zyvox).html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N09,Adapalene,S1276,Adapalene,10,m,9,14,25,192864427,412.52,106685-40-9,free base,Others,Adapalene is a third-generation topical retinoid primarily used in the treatment of acne.,C1(=C(C=CC(=C1)C2=CC3=C(C=C2)C=C(C=C3)C(O)=O)OC)C45CC6CC(C4)CC(C5)C6,19.39,http://www.selleckchem.com/products/Adapalene.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N10,Sumatriptan Succinate,S1432,Sumatriptan Succinate,10,m,10,14,25,192879006,413.49,103628-48-4,succinate,5-HT Receptor,Sumatriptan Succinate is a triptan sulfa drug containing a sulfonamide group for the treatment of migraine headaches.,C1(=CC=C2C(=C1)C(=CN2)CCN(C)C)CS(NC)(=O)=O.OC(CCC(O)=O)=O,200.73,http://www.selleckchem.com/products/Sumatriptan-succinate.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N11,Budesonide,S1286,Budesonide,10,m,11,14,25,192880878,430.53,51333-22-3,free base,Others,Budesonide is a glucocorticoid steroid for the treatment of asthma; non-infectious rhinitis.,C1C(C=C2[C@](C=1)([C@]3([C@@](CC2)([C@]4([C@](C[C@H]3O)([C@@]5([C@@H](C4)O[C@](O5)(CCC)[H])C(CO)=O)C)[H])[H])[H])C)=O,199.75,http://www.selleckchem.com/products/Budesonide.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N12,Ziprasidone HCl,S1444,Ziprasidone HCl,10,m,12,14,25,192881421,449.4,122883-93-6,hydrochloride,Others,Ziprasidone HCl is a novel and potentdopamineandserotonin (5-HT) receptorantagonist; used in the treatment of schizophrenia and bipolar disorder.,C1(=CC=CC2=C1C(=NS2)N3CCN(CC3)CCC4C(=CC5=C(C=4)CC(N5)=O)Cl).Cl,200.27,http://www.selleckchem.com/products/Ziprasidone-hydrochloride.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N13,Floxuridine,S1299,Floxuridine,10,m,13,14,25,192960065,246.19,50-91-9,free base,DNA/RNA Synthesis,Floxuridine is a prodrugs of floxuridine and an oncology agent with an GI50 of 5.1 _M for the inhibition of MDCK/PEPT1. Floxuridine is an antineoplastic antimetabolite; used in the treatment of colon carcinoma and colorectal cancer that has metastasized to the liver.,O1[C@@H]([C@H](C[C@H]1N2C=C(C(NC2=O)=O)F)O)CO,199.03,http://www.selleckchem.com/products/Floxuridine.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N14,Zibotentan (ZD4054),S1456,Zibotentan (ZD4054),10,m,14,14,25,179675789,424.43,186497-07-4,free base,Endothelin Receptor,Zibotentan (ZD4054) is a specific Endothelin (ET)A antagonist with IC50 of 21 nM; exhibiting no activity at ETB. Phase 3.,C1(C(=CC=CN=1)S(=O)(=O)NC2C(=NC(=CN=2)C)OC)C3C=CC(=CC=3)C4OC=NN=4,56.55,http://www.selleckchem.com/products/Zibotentan(ZD4054).html,GPCR & G Protein,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N15,Dexamethasone (DHAP),S1322,Dexamethasone (DHAP),10,m,15,14,25,192944244,392.46,50-02-2,free base,Autophagy;IL Receptor,Dexamethasone is a potent synthetic member of the glucocorticoid class of steroid drugs; and aninterleukin receptormodulator that has anti-inflammatory and immunosuppressant effects.,C1C(C=C2[C@](C=1)([C@]3([C@@](CC2)([C@]4([C@](C[C@H]3O)([C@@]([C@@H](C4)C)(C(=O)CO)O)C)[H])[H])F)C)=O,201.29,http://www.selleckchem.com/products/Dexamethasone.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N16,Doxercalciferol,S1467,Doxercalciferol,10,m,16,14,25,194475102,412.65,54573-75-0,free base,Others,Doxercalciferol is a syntheticvitamin D2analog; suppressing parathyroid synthesis and secretion; used to treat secondary hyperparathyroidism and metabolic bone disease.,C1[C@@H](C(/C(C[C@@H]1O)=C/C=C2\CCC[C@]3([C@]2(CC[C@]3([C@@H](/C=C/[C@H](C(C)C)C)C)[H])[H])C)=C)O,201.14,http://www.selleckchem.com/products/Doxercalciferol(Hectorol).html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N17,Fluoxetine HCl,S1333,Fluoxetine HCl,10,m,17,14,25,194474660,345.79,56296-78-7,hydrochloride,5-HT Receptor,Fluoxetine is a selectiveserotonin-reuptake inhibitor (SSRI) at the neuronal membrane; used in the treatment of depression.,C1(=CC=C(C=C1)OC(CCNC)C2=CC=CC=C2)C(F)(F)F.Cl,199.54,http://www.selleckchem.com/products/Fluoxetine-hydrochloride.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N18,Oligomycin A,S1478,Oligomycin A,10,m,18,14,25,179711843,791.06,579-13-5,free base,ATPase,Oligomycin A is an inhibitor of ATP synthase; inhibits oxidative phosphorylation and all the ATP-dependent processes occurring on the coupling membrane of mitochondria.,C1C[C@@]2(O[C@H]([C@@H]1C)C[C@@H](C)O)[C@H]([C@H]3[C@@]([C@@H](O2)CC[C@H](/C=C\C=C/C[C@H]([C@@H]([C@@](C([C@H]([C@]([C@H](C([C@H]([C@@H]([C@H](/C=C/C(O3)=O)C)O)C)=O)C)([H])O)C)=O)(C)O)O)C)CC)(C)[H])C,12.64,http://www.selleckchem.com/products/Oligomycin-A.html,Transmembrane Transporters,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N19,Ketoconazole,S1353,Ketoconazole,10,m,19,14,25,192960054,531.43,65277-42-1,free base,P450 (e.g. CYP17),Ketoconazole inhibits cyclosporine oxidase and testosterone 6 beta-hydroxylase with IC50 of 0.19 mM and 0.22 mM; respectively.,C1(=CC=C(C=C1)OC[C@@H]2O[C@@](OC2)(CN3C=CN=C3)C4=CC=C(C=C4Cl)Cl)N5CCN(CC5)C(=O)C,30.11,http://www.selleckchem.com/products/Ketoconazole.html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N20,PHA-793887,S1487,PHA-793887,10,m,20,14,25,192877987,361.48,718630-59-2,free base,CDK,PHA-793887 is a novel and potent inhibitor of CDK2; CDK5 and CDK7 with IC50 of 8 nM; 5 nM and 10 nM. It is greater than 6-fold more selective for CDK2; 5; and 7 than CDK1; 4; and 9. Phase 1.,N1N=C(C2=C1C(N(C2)C(C3CCN(CC3)C)=O)(C)C)NC(CC(C)C)=O,199.18,http://www.selleckchem.com/products/PHA-793887.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N21,Rigosertib (ON-01910),S1362,Rigosertib (ON-01910),10,m,21,14,25,192886643,473.47,1225497-78-8,sodium,PLK,Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Phase 3.,C1(=C(C=C(C=C1OC)OC)OC)/C=C/S(CC2=CC=C(C(=C2)NCC([O-])=O)OC)(=O)=O.[Na+],200.65,http://www.selleckchem.com/products/ON-01910.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,N22,Mycophenolate Mofetil,S1501,Mycophenolate Mofetil,10,m,22,14,25,194475227,433.49,128794-94-5,free base,Dehydrogenase,Mycophenolate Mofetil is a non-competitive; selective and reversible inhibitor of inosine monophosphate dehydrogenase I/II with IC50 of 39 nM and 27 nM; respectively.,C12=C(C(=C(C(=C1O)C/C=C(/CCC(OCCN3CCOCC3)=O)C)OC)C)COC2=O,200.7,http://www.selleckchem.com/products/Mycophenolate-mofetil-(CellCept).html,Metabolism,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O01,DMSO_O01,,DMSO_O01,,,1,15,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O02,DMSO_O02,,DMSO_O02,,,2,15,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O03,PD184352 (CI-1040),S1020,PD184352 (CI-1040),10,m,3,15,25,192903240,478.67,212631-79-3,free base,MEK,CI-1040 (PD 184352) is an ATP non-competitive MEK1/2 inhibitor with IC50 of 17 nM; 100-fold more selective for MEK1/2 than MEK5. Phase 2.,C1=C(C(=C(C(=C1)C(NOCC2CC2)=O)NC3=CC=C(C=C3Cl)I)F)F,200.56,http://www.selleckchem.com/products/CI-1040-(PD184352).html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O04,Alisertib (MLN8237),S1133,Alisertib (MLN8237),10,m,4,15,25,192881409,518.92,1028486-01-2,free base,Aurora Kinase,Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM. It has >200-fold higher selectivity for Aurora A than Aurora B. Phase 3.,C1=CC=C(C(=C1OC)C2=NCC3=C(C4=C2C=C(C=C4)Cl)N=C(N=C3)NC5=CC(=C(C=C5)C(O)=O)OC)F,107.92,http://www.selleckchem.com/products/MLN8237.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O05,Panobinostat (LBH589),S1030,Panobinostat (LBH589),10,m,5,15,25,192902851,349.43,404950-80-7,free base,HDAC,Panobinostat (LBH589) is a novel broad-spectrum HDAC inhibitor with IC50 of 5 nM. Phase 3.,C1(=CC=C(C=C1)/C=C/C(=O)NO)CNCCC2=C(NC3=C2C=CC=C3)C,200.33,http://www.selleckchem.com/products/LBH-589.html,Epigenetics,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O06,AG-490 (Tyrphostin B42),S1143,AG-490 (Tyrphostin B42),10,m,6,15,25,192867653,294.3,133550-30-8,free base,JAK;EGFR,AG-490 (Tyrphostin B42) is an inhibitor of EGFR with IC50 of 0.1 ?M in cell-free assays; 135-fold more selective for EGFR versus ErbB2; also inhibits JAK2 with no activity to Lck; Lyn; Btk; Syk and Src.,C1(=C(C=CC(=C1)/C=C(/C(NCC2=CC=CC=C2)=O)C#N)O)O,200.48,http://www.selleckchem.com/products/AG-490.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O07,Sorafenib Tosylate,S1040,Sorafenib Tosylate,10,m,7,15,25,192880408,637.03,475207-59-1,tosylate,PDGFR;Raf;VEGFR,Sorafenib Tosylate (Bay 43-9006) is a multikinase inhibitor of Raf-1; B-Raf and VEGFR-2 with IC50 of 6 nM; 22 nM and 90 nM; respectively.,C1(=CC=C(C=C1C(F)(F)F)NC(NC2=CC=C(C=C2)OC3=CC=NC(=C3)C(NC)=O)=O)Cl.C4=CC(=CC=C4S(O)(=O)=O)C,199.36,http://www.selleckchem.com/products/Sorafenib-Tosylate.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O08,SNS-314 Mesylate,S1154,SNS-314 Mesylate,10,m,8,15,25,194472581,527.04,1146618-41-8,mesylate,Aurora Kinase,SNS-314 Mesylate is a potent and selective inhibitor of Aurora A; Aurora B and Aurora C with IC50 of 9 nM; 31 nM; and 3 nM; respectively. It is less potent to Trk A/B; Flt4; Fms; Axl; c-Raf and DDR2. Phase 1.,C12(=C(N=CN=C1NCCC3SC(=NC=3)NC(NC4=CC(=CC=C4)Cl)=O)C=CS2).CS(=O)(=O)O,163.18,http://www.selleckchem.com/products/SNS-314.html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O09,VX-680 (Tozasertib; MK-0457),S1048,VX-680 (Tozasertib; MK-0457),10,m,9,15,25,179703511,464.59,639089-54-6,free base,Aurora Kinase,VX-680 (Tozasertib; MK-0457) is a pan-Aurora inhibitor; mostly against Aurora A with Kiapp of 0.6 nM; less potent towards Aurora B/Aurora C and 100-fold more selective for Aurora A than 55 other kinases. Phase 2.,C1(=CC(=NC(=N1)SC2=CC=C(C=C2)NC(=O)C3CC3)N4CCN(CC4)C)NC5C=C(NN=5)C,200.18,http://www.selleckchem.com/products/VX-680(MK-0457).html,Cell Cycle,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O10,Lenvatinib (E7080),S1164,Lenvatinib (E7080),10,m,10,15,25,192886483,426.85,417716-92-8,free base,VEGFR,E7080 (Lenvatinib) is a multi-target inhibitor; mostly for VEGFR2(KDR)/VEGFR3(Flt-4) with IC50 of 4 nM/5.2 nM; less potent against VEGFR1/Flt-1; ~10-fold more selective for VEGFR2/3 against FGFR1; PDGFR_/_. Phase 3.,C1(=C(C=C2C(=C1)C(=CC=N2)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl)OC)C(N)=O,93.71,http://www.selleckchem.com/products/E7080.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O11,Nutlin-3,S1061,Nutlin-3,10,m,11,15,25,192946805,581.5,890090-75-2,free base,E3 Ligase ;Mdm2,Nutlin-3 is a potent and selective Mdm2 (RING finger-dependent ubiquitin protein ligase for itself and p53) antagonist with IC50 of 90 nM; stabilizes p73 in p53-deficient cells.,N1(C(C(N=C1C2=C(C=C(C=C2)OC)OC(C)C)C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)Cl)C(=O)N5CCNC(C5)=O,171.97,http://www.selleckchem.com/products/Nutlin-3.html,Apoptosis,,L1300-Selleck-FDA-Approved-Drug-Library
SelleckChem001,SP0135-A,O12,JNJ-26854165 (Serdemetan),S1172,JNJ-26854165 (Serdemetan),10,m,12,15,25,192885808,328.41,881202-45-5,free base,p53;E3 Ligase ,JNJ-26854165 (Serdemetan) acts as a HDM2 ubiquitin ligase antagonist and also induces early apoptosis in p53 wild-type cells; inhibits cellular proliferation followed by delayed apoptosis in the absence of functional p53. Phase 1.,C1=C2C(=CC=C1)NC=C2CCNC3=CC=C(C=C3)NC4=CC=NC=C4,200.97,http://www.selleckchem.com/products/JNJ-26854165.html,Apoptosis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O13,HA14-1,S1071,HA14-1,10,m,13,15,25,179764927,409.23,65673-63-4,free base,Bcl-2,HA14-1 is a non-peptidic ligand of a Bcl-2 surface pocket with IC50 of ~9 ?M.,C1=C(C=C2C(=C1)OC(=C([C@@]2([C@H](C#N)C(OCC)=O)[H])C(OCC)=O)N)Br,200.38,http://www.selleckchem.com/products/HA14-1.html,Apoptosis,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O14,XAV-939,S1180,XAV-939,10,m,14,15,25,179703996,312.31,284028-89-3,free base,Wnt/beta-catenin,XAV-939 selectively inhibits Wnt/?-catenin-mediated transcription through tankyrase1/2 inhibition with IC50 of 11 nM/4 nM in cell-free assays; regulates axin levels and does not affect CRE; NF-?B or TGF-?.,C1=CC(=CC=C1C(F)(F)F)C2=NC(=C3C(=N2)CCSC3)O,38.42,http://www.selleckchem.com/products/XAV-939.html,Stem Cells &  Wnt,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O15,Brivanib (BMS-540215),S1084,Brivanib (BMS-540215),10,m,15,15,25,192885953,370.38,649735-46-6,free base,FGFR;VEGFR,Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM; moderate potency against VEGFR-1 and FGFR-1; but >240-fold against PDGFR-_. Phase 3.,C12=C(C(=C(C=C1)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)O)C)F)C=C(N2)C,199.79,http://www.selleckchem.com/products/Brivanib.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O16,Fulvestrant,S1191,Fulvestrant,10,m,16,15,25,192885804,606.77,129453-61-8,free base,Estrogen/progestogen Receptor,Fulvestrant is an estrogen receptor (ER) antagonist with IC50 of 0.094 nM.,C1(C=CC2[C@@]3(CC[C@]4([C@H](CC[C@@]([C@]([C@@H](CC(C=1)=2)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F)3[H])4[H])O)C)[H])O,164.81,http://www.selleckchem.com/products/Fulvestrant.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O17,GSK1904529A,S1093,GSK1904529A,10,m,17,15,25,179703194,851.96,1089283-49-7,free base,IGF-1R,GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM; >100-fold more selective for IGF-1R/InsR than Akt1/2; Aurora A/B;B-Raf; CDK2; EGFR etc.,C1=C(C(=C(C=C1)F)NC(C2=C(C=CC(=C2)C3=C(N4C(=N3)C=CC=C4)C5=CC=NC(=N5)NC6=C(C=C(C(=C6)CC)N7CCC(CC7)N8CCN(CC8)S(C)(=O)=O)OC)OC)=O)F,145.55,http://www.selleckchem.com/products/GSK1904529A.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O18,Cladribine,S1199,Cladribine,10,m,18,15,25,192878442,285.69,4291-63-8,free base,DNA/RNA Synthesis,Cladribine is an adenosine deaminase inhibitor for U266; RPMI8226; and MM1.S cells with IC50 of approximately 2.43 _M; 0.75 _M; and 0.18 _M; respectively.,N1=C(C2=C(N=C1Cl)N(C=N2)[C@H]3C[C@@H]([C@H](O3)CO)O)N,199.52,http://www.selleckchem.com/products/Cladribine.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O19,U0126-EtOH,S1102,U0126-EtOH,10,m,19,15,25,179704029,426.56,1173097-76-1,ethanolat,MEK,U0126-EtOH is a highly selective inhibitor of MEK1/2 with IC50 of 0.07 _M/0.06 _M; 100-fold higher affinity for _N3-S218E/S222D MEK than PD098059.,C1(=CC=C(C(=C1)SC(/N)=C(\C(=C(\SC2=C(C=CC=C2)N)N)C#N)C#N)N).CCO,199.27,http://www.selleckchem.com/products/U0126.html,MAPK,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O20,Doxorubicin (Adriamycin),S1208,Doxorubicin (Adriamycin),10,m,20,15,25,192917385,579.98,25316-40-9,hydrochloride,Autophagy;Topoisomerase,Doxorubicin (Adriamycin) is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis.,C1(=CC=C2C(=C1OC)C(C3=C(C2=O)C(=C4C(=C3O)[C@@H](C[C@@](C4)(C(CO)=O)O)O[C@]5(C[C@@H]([C@@H]([C@@H](O5)C)O)N)[H])O)=O).Cl,172.42,http://www.selleckchem.com/products/Adriamycin.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O21,Foretinib (GSK1363089),S1111,Foretinib (GSK1363089),10,m,21,15,25,194475557,632.65,849217-64-7,free base,VEGFR;c-Met,Foretinib (GSK1363089) is an ATP-competitive inhibitor of HGFR and VEGFR; mostly for Met and KDR with IC50 of 0.4 nM and 0.9 nM. Less potent against Ron; Flt-1/3/4; Kit; PDGFR_/_ and Tie-2; and little activity to FGFR1 and EGFR. Phase 2.,C1(=CC=C(C=C1)F)NC(C2(C(NC3=CC(=C(C=C3)OC4C5=C(N=CC=4)C=C(C(=C5)OC)OCCCN6CCOCC6)F)=O)CC2)=O,200.74,"https://www.selleckchem.com/products/XL880(GSK1363089,EXEL-2880).html",Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,O22,YM201636,S1219,YM201636,10,m,22,15,25,194487298,467.48,371942-69-7,free base,PI3K,YM201636 is a selective PIKfyve inhibitor with IC50 of 33 nM; less potent to p110_ and insensitive to Fabl (yeast orthologue).,C1C(=CC=C(N=1)N)C(=O)NC2C=C(C=CC=2)C3N=C4C(=C(N=3)N5CCOCC5)OC6C(=CC=CN=6)4,74.87,http://www.selleckchem.com/products/ym201636.html,PI3K/Akt/mTOR,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P01,DMSO_P01,,DMSO_P01,,,1,16,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P02,DMSO_P02,,DMSO_P02,,,2,16,,,,,,,,,,,,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P03,Vincristine,S1241,Vincristine,10,m,3,16,25,192878305,923.04,2068-78-2,sulfate,Microtubule Associated;Autophagy,Vincristine is an inhibitor of polymerization of microtubules by binding to tubulin with IC50 of 32 _M.,C1(=CC2=C(C=C1[C@@]3(C4=C(C5=C(N4)C=CC=C5)CCN6C[C@](C3)(C[C@@](C6)(O)CC)[H])C(OC)=O)[C@]78[C@@](N2C=O)([C@]([C@@H]([C@]9([C@@]7(N(CC8)CC=C9)[H])CC)OC(=O)C)(C(OC)=O)O)[H])OC.S(=O)(=O)(O)O,108.34,http://www.selleckchem.com/products/Vincristine-Sulfate.html,Cytoskeletal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P04,Naftopidil DiHCl,S1387,Naftopidil DiHCl,10,m,4,16,25,192946816,465.41,57149-08-3,dihydrochloride,Adrenergic Receptor,Naftopidil DiHCl is a selective 5-HT1A and ?1-adrenergic receptor antagonist with IC50 of 0.1 ?M and 0.2 ?M; respectively.,C1(=C2C(=CC=C1)C=CC=C2)OCC(CN3CCN(CC3)C4=CC=CC=C4OC)O.Cl.Cl,88.09,http://www.selleckchem.com/products/Naftopidil-Dihydrochloride.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P05,Entecavir Hydrate,S1252,Entecavir Hydrate,10,m,5,16,25,192864417,295.29,209216-23-9,hydrate,Others,Entecavir; a new deoxyguanine nucleoside analogue; is a selective inhibitor of the replication of the hepatitis B virus (HBV).,N1(=C(NC2=C(C1=O)N=CN2[C@H]3C[C@@H]([C@H](C3=C)CO)O)N).O,199.8,https://www.selleckchem.com/products/s1252-entecavir.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P06,Rocuronium Bromide,S1397,Rocuronium Bromide,10,m,6,16,25,192878274,609.68,119302-91-9,bromide,AChR,Rocuronium Bromide is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant.,[C@H]1([C@H](C[C@]2([C@](C1)([C@]3([C@@](CC2)([C@]4([C@](CC3)([C@@H]([C@H](C4)[N+]5(CCCC5)CC=C)OC(=O)C)C)[H])[H])[H])C)[H])O)N6(CCOCC6).[Br-],200.1,http://www.selleckchem.com/products/Rocuronium-bromide.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P07,Avagacestat (BMS-708163),S1262,Avagacestat (BMS-708163),10,m,7,16,25,181346020,520.88,1146699-66-2,free base,Gamma-secretase;Beta Amyloid,Avagacestat (BMS-708163) is a potent; selective; orally bioavailable _-secretase inhibitor of A_40 and A_42 with IC50 of 0.3 nM and 0.27 nM; demonstrating a 193-fold selectivity against Notch. Phase 2.,C1(=C(C=C(C=C1)C2N=CON=2)F)CN([C@@H](C(N)=O)CCC(F)(F)F)S(C3=CC=C(C=C3)Cl)(=O)=O,199.66,http://www.selleckchem.com/products/BMS-708163.html,Proteases,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P08,Alfuzosin HCl ,S1409,Alfuzosin HCl ,10,m,8,16,25,192879257,425.91,81403-68-1,hydrochloride,Adrenergic Receptor,Alfuzosin(Uroxatral) is an alpha1 receptor antagonist used to treat benign prostatic hyperplasia (BPH). ,C1(=C(C=C2C(=C1)C(=NC(=N2)N(CCCNC(C3CCCO3)=O)C)N)OC)OC.Cl,199.57,http://www.selleckchem.com/products/Alfuzosin-hydrochloride.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P09,Altretamine,S1278,Altretamine,10,m,9,16,25,192864313,210.28,645-05-6,free base,Others,Altretamine is an anti-neoplastic agent.,N1=C(N=C(N=C1N(C)C)N(C)C)N(C)C,71.33,http://www.selleckchem.com/products/Altretamine.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P10,Tianeptine sodium,S1436,Tianeptine sodium,10,m,10,16,25,192918058,458.93,30123-17-2,sodium,5-HT Receptor,Tianeptine is a selective serotonin reuptake enhancer (SSRE) compound used for treating major depressive episodes.,C12(=C(C(C3C(S(N1C)(=O)=O)=CC(=CC=3)Cl)NCCCCCCC(=O)[O-])C=CC=C2).[Na+],198.29,http://www.selleckchem.com/products/Tianeptine-sodium-salt.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P11,Bumetanide,S1287,Bumetanide,10,m,11,16,25,192897292,364.42,28395-03-1,free base,Others,Bumetanide (Bumex) is a loop diuretic of the sulfamyl category to treat heart failure.,C1=C(C(=C(C=C1C(=O)O)NCCCC)OC2=CC=CC=C2)S(=O)(=O)N,200.32,http://www.selleckchem.com/products/Bumetanide.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P12,Zonisamide,S1445,Zonisamide,10,m,12,16,25,192959482,212.23,68291-97-4,free base,Others,Zonisamide is a voltage-dependent sodium channel and T-type calcium channel blocker; used as an antiepileptic drug.,C12=CC=CC=C1ON=C2CS(N)(=O)=O,197.9,http://www.selleckchem.com/products/Zonisamide.html,Others,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P13,FT-207 (NSC 148958),S1300,FT-207 (NSC 148958),10,m,13,16,25,192879917,200.17,17902-23-7,free base,DNA/RNA Synthesis,FT-207 (NSC 148958) is a substance being used in the treatment of some types of cancer.,N1C(N(C=C(C1=O)F)[C@@H]2OCCC2)=O,199.83,http://www.selleckchem.com/products/Ftorafur.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P14,Atazanavir Sulfate,S1457,Atazanavir Sulfate,10,m,14,16,25,192898515,802.93,229975-97-7,sulfate,HIV Protease,Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM.,O(C(N[C@H](C(N[C@H]([C@H](CN(NC([C@@H](NC(OC)=O)C(C)(C)C)=O)CC1=CC=C(C=C1)C2=NC=CC=C2)O)CC3=CC=CC=C3)=O)C(C)(C)C)=O)C.S(=O)(=O)(O)O,129.53,http://www.selleckchem.com/products/Atazanavir.html,Proteases,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P15,Doxazosin Mesylate,S1324,Doxazosin Mesylate,10,m,15,16,25,192886983,547.58,77883-43-3,mesylate,Adrenergic Receptor,Doxazosin; a quinazoline-derivative; selectively antagonizes postsynaptic ?1-adrenergic receptors; used in the treatment of high blood pressure and urinary retention associated with benign prostatic hyperplasia.,C12(=CC(=C(C=C1C(=NC(=N2)N3CCN(CC3)C(C4COC5=C(O4)C=CC=C5)=O)N)OC)OC).S(=O)(O)(=O)C,27.39,http://www.selleckchem.com/products/Doxazosin-mesylate.html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P16,Alfacalcidol,S1468,Alfacalcidol,10,m,16,16,25,192881587,400.64,41294-56-8,free base,Others,Alfacalcidol is a non-selective VDR activator medication.,C1[C@H](C[C@@H](C(C/1=C\C=C2/[C@]3([C@](CCC2)([C@H](CC3)[C@@H](CCCC(C)C)C)C)[H])=C)O)O,199.68,http://www.selleckchem.com/products/Alfacalcidol.html,Endocrinology & Hormones,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P17,Flupirtine maleate,S1334,Flupirtine maleate,10,m,17,16,25,192878026,420.39,75507-68-5,maleate,DNA/RNA Synthesis,Flupirtine maleate is the salt form of Flupirtine; which is a centrally acting non-opioid analgesia; is a selective neuronal potassium channel opener that also has NMDA receptor antagonist properties. Phase 2.,C1(=CC=C(C=C1)CNC2=NC(=C(C=C2)NC(=O)OCC)N)F.OC(/C=C/C(O)=O)=O,199.81,http://www.selleckchem.com/products/Flupirtine-maleate.html,DNA Damage,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P18,VX-222 (VCH-222; Lomibuvir),S1480,VX-222 (VCH-222; Lomibuvir),10,m,18,16,25,192949493,445.61,1026785-59-0,free base,HCV Protease,Lomibuvir (VX-222; VCH-222) is a novel; potent and selective inhibitor of HCV polymerase with IC50 of 0.94-1.2 ?M; 15.3-fold less effective for mutant M423T; and 108-fold less effective for mutant I482L. Phase 2.,[C@H]1(CC[C@@H](CC1)O)N(C2=C(SC(=C2)C#CC(C)(C)C)C(O)=O)C(=O)[C@@H]3CC[C@H](CC3)C,199.73,http://www.selleckchem.com/products/VX-222.html,Proteases,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P19,Lansoprazole,S1354,Lansoprazole,10,m,19,16,25,192878091,369.36,103577-45-3,free base,Proton Pump,Lansoprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid.,C1=CC=C2C(=C1)N=C(N2)S(CC3=NC=CC(=C3C)OCC(F)(F)F)=O,200.35,http://www.selleckchem.com/products/Lansoprazole.html,Transmembrane Transporters,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P20,Naratriptan ,S1488,Naratriptan ,10,m,20,16,25,192948817,371.93,143388-64-1,free base,5-HT Receptor,Naratriptan is a triptan agent that is used for the treatment of migraine headaches.,C1(=CC=C2C(=C1)C(=CN2)C3CCN(CC3)C)CCS(=O)(=O)NC.Cl,198.96,http://www.selleckchem.com/products/Naratriptan(Amerge).html,Neuronal Signaling,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P21,Ki8751,S1363,Ki8751,10,m,21,16,25,192879077,469.41,228559-41-9,free base,PDGFR;c-Kit;VEGFR,Ki8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM; >40-fold selective for VEGFR2 than c-Kit; PDGFR_ and FGFR-2; little activity to EGFR; HGFR and InsR.,C1=CN=C2C(=C1OC3=CC=C(C(=C3)F)NC(NC4=CC=C(C=C4F)F)=O)C=C(C(=C2)OC)OC,100.13,http://www.selleckchem.com/products/Ki8751.html,Protein Tyrosine Kinase,,L1700-Selleck-Bioactive-Compound-Library
SelleckChem001,SP0135-A,P22,Cephalexin,S1502,Cephalexin,10,m,22,16,25,192896661,347.39,15686-71-2,free base,Others,Cephalexin is an antibiotic that can treat a number of bacterial infections.,C1=CC=C(C=C1)[C@H](C(N[C@@H]2C(N3[C@]2(SCC(=C3C(=O)O)C)[H])=O)=O)N,5.75,http://www.selleckchem.com/products/Cephalexin-(Cefalexin).html,Others,,L1700-Selleck-Bioactive-Compound-Library
